0001214659-22-007321 10-Q 43 20220331 20220523 20220523 Ault Disruptive Technologies Corp 0001864032 6770 862279256 DE 1231 10-Q 34 001-41171 22951736 11411 SOUTHERN HIGHLANDS PKWY 240 LAS VEGAS NV 89141 (949) 444-5464 11411 SOUTHERN HIGHLANDS PKWY 240 LAS VEGAS NV 89141 10-Q 1 adtc51022010q.htm
0001864032 false 2022 Q1 --12-31 116,725,000 P12M P15M P18M 0 2875000 2,875,000 P12M P15M P18M 0001864032 2022-01-01 2022-03-31 0001864032 adrt:CommonStock0.001ParValueMember 2022-01-01 2022-03-31 0001864032 adrt:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member 2022-01-01 2022-03-31 0001864032 2022-05-13 0001864032 2022-03-31 0001864032 2021-12-31 0001864032 2021-02-22 2021-03-31 0001864032 us-gaap:CommonStockMember 2021-12-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001864032 us-gaap:RetainedEarningsMember 2021-12-31 0001864032 us-gaap:CommonStockMember 2021-02-22 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-02-22 0001864032 us-gaap:RetainedEarningsMember 2021-02-22 0001864032 2021-02-22 0001864032 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001864032 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001864032 us-gaap:CommonStockMember 2021-02-23 2021-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-02-23 2021-03-31 0001864032 us-gaap:RetainedEarningsMember 2021-02-23 2021-03-31 0001864032 2021-02-23 2021-03-31 0001864032 us-gaap:CommonStockMember 2022-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001864032 us-gaap:RetainedEarningsMember 2022-03-31 0001864032 us-gaap:CommonStockMember 2021-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001864032 us-gaap:RetainedEarningsMember 2021-03-31 0001864032 2021-03-31 0001864032 2021-02-21 0001864032 us-gaap:IPOMember 2021-12-13 2021-12-15 0001864032 us-gaap:IPOMember 2021-12-15 0001864032 us-gaap:PrivatePlacementMember 2021-12-18 2021-12-20 0001864032 us-gaap:IPOMember 2022-03-31 0001864032 us-gaap:OverAllotmentOptionMember 2022-03-31 0001864032 us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:PrivatePlacementMember 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember 2021-12-18 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:IPOMember 2021-11-19 2021-11-20 0001864032 us-gaap:IPOMember 2021-12-19 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember 2021-12-19 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-20 0001864032 us-gaap:PrivatePlacementMember 2021-12-19 2021-12-20 0001864032 adrt:SponsorMember 2021-02-23 2021-03-31 0001864032 2021-02-23 0001864032 adrt:SponsorMember us-gaap:PrivatePlacementMember 2022-01-01 2022-03-31 0001864032 adrt:SponsorMember us-gaap:PrivatePlacementMember 2022-03-31 0001864032 us-gaap:PrivatePlacementMember 2022-03-31 0001864032 adrt:PrivatePlacement1Member 2022-03-31 0001864032 adrt:PrivatePlacement2Member 2022-03-31 0001864032 adrt:SponsorMember 2022-01-01 2022-03-31 0001864032 adrt:FounderSharesMember 2021-02-23 0001864032 adrt:SponsorMember adrt:PrivatePlacement1Member 2022-01-01 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001864032 us-gaap:FairValueInputsLevel1Member 2022-03-31 0001864032 us-gaap:FairValueInputsLevel2Member 2022-03-31 0001864032 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember 2021-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001864032 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001864032 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001864032 us-gaap:FairValueInputsLevel3Member 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

  (Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 001-41171

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Delaware 86-2279256
(State or other jurisdiction of incorporation or organization)  (I.R.S. Employer Identification Number)

 

11411 Southern Highlands Pkwy, Suite 240,

Las Vegas, NV

89141 (949) 444-5464
(Address of principal executive offices) (Zip Code) (Registrant’s telephone number, including area code)

 

Securities registered under Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

  Name of each exchange on which registered
Common Stock, $0.001 par value   ADRT   NYSE American
Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50   ADRTW   NYSE American

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x   No  ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act

 

Large accelerated filer ¨ Accelerated filer ¨
       
Non-accelerated Filer x Smaller reporting company x
       
    Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes x    No  ☐

 

As of May 23, 2022, there were 2,875,000 outstanding shares of the registrant’s common stock, $0.001 par value per share.

 

 

   
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

Quarterly Report on Form 10-Q

Table of Contents 

 

PART I. FINANCIAL INFORMATION 1
     
Item 1. Financial Statements 1
     
  Condensed Balance Sheets as of March 31, 2022 (unaudited) and December 31, 2021 1
     
  Unaudited Condensed Statements of Operations for the Three Months Ended March 31, 2022 and for the Period
February 22, 2021 (inception) to March 31, 2021
2
     
  Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the Three Months Ended March 31, 2022 and for the
Period February 22, 2021 (inception) to March 31, 2021
3
     
  Unaudited Condensed Statements of Cash Flows for the Three Months Ended March 31, 2022 and for the Period
February 22, 2021 (inception) to March 31, 2021
4
     
  Notes to Unaudited Condensed Financial Statements 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 20
     
Item 4. Controls and Procedures 20
   
PART II. OTHER INFORMATION 21
     
Item 1. Legal Proceedings 21
     
Item 1A. Risk Factors 21
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 21
     
Item 3. Defaults Upon Senior Securities 21
     
Item 4. Mine Safety Disclosures 21
     
Item 5. Other Information 21
     
Item 6. Exhibits 22
   
SIGNATURES 23

 

   
 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

CONDENSED BALANCE SHEETS

 

   March 31, 2022   December 31, 2021 
   (unaudited)     
Assets        
Current asset - cash  $1,109,623   $1,849,679 
Prepaid expenses   419,817    395,000 
Total current assets   1,529,440    2,244,679 
Prepaid expenses, non-current   293,582    375,000 
Cash and securities held in Trust Account   116,736,920    116,725,166 
Total Assets  $118,559,942   $119,344,845 
Liabilities and Stockholders’ Equity          
Current liabilities:          
Accounts payable  $80,659   $173,390 
Accrued offering costs and expenses   356,018    759,990 
Total current liabilities   436,677    933,380 
Deferred underwriting commissions   3,450,000    3,450,000 
Total liabilities   3,886,677    4,383,380 
Commitments          
Common stock subject to possible redemption, 11,500,000
shares at redemption value
   116,725,000    116,725,000 
Stockholders’ Deficit:          
Preferred stock, $0.001 par value; 1,000,000 shares authorized; none
issued and outstanding
        
Common stock, $0.001 par value; 100,000,000 shares authorized;
2,875,000 shares issued and outstanding
   2,875    2,875 
Additional paid-in capital        
Accumulated deficit   (2,054,610)   (1,766,410)
Total stockholders’ deficit   (2,051,735)   (1,763,535)
Total Liabilities and Stockholders’ Deficit  $118,559,942   $119,344,845 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 1 
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

 

   Three Month ended
March 31, 2022
   For the
Period From
February 22, 2021
(inception) to
March 31, 2021
 
Formation and operating costs  $296,891   $958 
Loss from operations   (296,891)   (958)
           
Other income          
Trust interest income        
Interest expense   (3,063)    
Income from investments held in trust account   11,754     
Total other income   8,691     
           
Net loss  $(288,200)  $(958)
           
Basic and diluted weighted average shares outstanding, common stock subject to
redemption
   11,500,000     
Basic and diluted net income per share attributable to common stock subject to
redemption
  $(0.02)  $ 
           
Basic and diluted weighted average shares outstanding, common stock   2,875,000    2,500,000 
Basic and diluted net loss per share attributable to common stockholders  $(0.02)  $(0.00)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 2 
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND FOR THE PERIOD
FEBRUARY 22, 2021 (INCEPTION) TO MARCH 31, 2021

 

                           
   Common Stock   Additional   Accumulated  

Total

Stockholders'

 
   Shares   Amount   Paid-in Capital   Deficit   Deficit 
Balance as of December 31, 2021   2,875,000   $2,875   $   $(1,766,410)  $(1,763,535)
Net loss               (288,200)   (288,200)
Balance as of March 31, 2022   2,875,000   $2,875   $   $(2,054,610)  $(2,051,735)

 

                     
   Common Stock   Additional   Accumulated  

Total

Stockholders'

 
   Shares   Amount   Paid-in Capital   Deficit   Deficit 
Balance as of February 22, 2021 (inception)     $    $    $    $  
Issuance of common stock to sponsor   2,875,000    2,875    22,125        25,000 
Net loss               (958)   (958)
Balance as of March 31, 2021   2,875,000   $2,875   $22,125   $(958)  $24,052 

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 3 
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

 

  

For the three

months ended

March 31, 2022

   For the Period
From February 22,
2021 (inception) to
March 31, 2021
 
Cash Flows from Operating Activities:        
Net loss  $(288,200)  $(958)
Adjustments to reconcile net loss to net cash used in operating activities:          
Interest earned on Trust Account        
Income from investments held in Trust Account   (11,754)    
Changes in current assets and current liabilities:          
Prepaid expenses   56,601     
Accrued offering costs and expenses   (346,067)   958 
Net cash used in operating activities   (589,420)    
Cash Flows from Investing Activities:          
Net cash used in investing activities        
Cash Flows from Financing Activities:          
Payments of offering costs   (150,636)    
Net cash used in financing activities   (150,636)    
Net change in cash   (740,056)    
Cash, beginning of the period   1,849,679     
Cash, end of the period  $1,109,623   $ 
Supplemental disclosure of noncash investing and financing activities:          
Deferred offering costs included in accrued offering costs and accounts
payable
  $   $54,033 
Payment of deferred offering costs by the Sponsor in exchange for the
issuance of common stock
  $   $25,000 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 4 
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 1 — Organization and Business Operations

 

Organization and General

 

Ault Disruptive Technologies Corporation (the “Company”) is a blank check company organized on February 22, 2021, under the laws of the State of Delaware. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies with innovative and emerging technologies, products or services in the United States.

 

As of March 31, 2022, the Company had not commenced any operations. All activity for the period from February 22, 2021 (inception) through March 31, 2022, relates to the Company’s formation, the public offering described below and the search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering (the “IPO” or “Public Offering”). The Company has selected December 31 as its fiscal year end.

 

The Company’s Sponsor is Ault Disruptive Technologies Company, LLC (the “Sponsor”).

 

Financing 

 

The registration statement for the Company’s IPO was declared effective on December 15, 2021 (the “Effective Date”). On December 20, 2021, the Company consummated its IPO of 10,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one share of common stock, par value of $0.001 per share (the “Common Stock”), and three-fourths of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share. On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000. 

 

Simultaneously with the consummation of the IPO, the Company consummated the private placement of 6,500,000 warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor, at a price of $1.00 per Private Placement Warrant in a private placement. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000

 

Transaction costs related to the IPO amounted to $6,297,333 consisting of $2,513,333 of underwriting commissions, $3,000,000 of deferred underwriting commissions, and $784,000 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $7,122,333 consisting of $2,888,333 of underwriting commissions, $3,450,000 of deferred underwriting commissions, and $784,000 of other offering costs. In addition, $1,109,623 of cash was held outside of the Trust Account (as defined below) as of March 31, 2022 and is available for working capital purposes.

 

Initial Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

 

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

 

 5 
 

 

Trust Account

 

Following the closing of the IPO on December 20, 2021, $116,725,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.15 per Unit for the 11,500,000 Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $116,725,000 was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The trust account is intended as a holding place for funds pending the earliest to occur of: (i) the consummation of the Company’s initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation (A) to modify the substance or timing of its obligation to allow redemptions in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto or to redeem 100% of the Company’s public shares if the Company does not consummate its initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering, the Company’s return of the funds held in the trust account to its public stockholders as part of its redemption of the public shares. If the Company does not invest the proceeds as discussed above, the Company may be deemed to be subject to the Investment Company Act. If the Company is deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which the Company has not allotted funds and may hinder its ability to consummate an initial Business Combination or may result in its liquidation. If the Company is unable to consummate its initial Business Combination, the Company’s public stockholders may receive only approximately $10.15 per public share, or $10.25 or $10.35 per public share, as applicable, on the liquidation of the Company’s trust account and its warrants will expire worthlessly.

 

The Company will provide holders (the “Public Shareholders”) of its Common Stock sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely at its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement.

 

The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Common Stock upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is currently anticipated to be $10.15 per public share.

 

The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close. 

 

 6 
 

 

The Common Stock subject to redemption was recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company’s amended and restated articles of incorporation provides that the Company will have only 12 months following the effectiveness of the Public Offering (or up to 18 months following the effectiveness of the Public Offering if the Company extends the period of time to consummate a Business Combination, subject to the Sponsor depositing additional funds in the Trust Account) (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $50,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period.

 

The Sponsor and each member of its management team have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (defined in Note 5), Private Placement Warrants and Public Shares held by them (ii) to waive their redemption rights with respect to their Founder Shares, Private Placement Warrants and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) that would modify the substance or timing of the Company’s obligation to provide holders of shares of Common Stock the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within Combination Period or (B) with respect to any other provision relating to the rights of holders of shares of Common Stock or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Warrants they hold if the Company fails to consummate an initial Business Combination within Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).

 

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Private Placement Warrants if the Company fails to consummate a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to consummate a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not consummate a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.15, or $10.25 or $10.35 per Public Share, as applicable). 

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.15 per Public Share, or $10.25 or $10.35 per Public Share, as applicable, and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

 7 
 

 

Liquidity and Going Concern

 

As of March 31, 2022, the Company had approximately $1.1 million in its operating bank account and working capital of approximately $1.1 million.

 

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

 

The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In addition, if the Company is unable to consummate the Business Combination within 12 months following the effectiveness of the Initial Public Offering, which is December 15, 2022, the Company may, but is not obligated to, extend the period of time to complete the Business Combination up to two times by an additional three months each time (for a total of up to 18 months to consummate an initial business combination). If the period of time is not extended, the Company will be required to cease all operations except for the purpose of winding up. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date that the financial statement were issued. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Risks and Uncertainties

 

The Company has a limited operating history and has not yet generated revenue from intended operations. The Company’s business and operations are sensitive to general business and economic conditions in the U.S. along with local, state, and federal government policy decisions. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including but not limited to, credit risk, and changes to regulations governing the Company’s industry. Adverse developments in this general business and economic conditions could have a material adverse effect on the Company’s financial condition and the results of its operations. 

 

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or searching for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

 

Note 2 — Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 15, 2022.

 

 8 
 

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

 

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company intends to take advantage of the benefits of this extended transition period.

 

The Company will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the effectiveness of the Initial Public Offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.

 

Additionally, the Company is a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates equals or exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30th.  

 

Use of Estimates

 

The preparation of the financial statements are in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Accounting Policy on Redeemable Shares

 

The Company will account for its Common Stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, shares of common stock will be classified as shareholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Accordingly, 11,500,000 shares of Common Stock are subject to possible redemption, which are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. 

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid-in capital and accumulated deficit. 

 

 9 
 

 

As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:

 

      
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (4,312,500)
Issuance costs allocated to common stock   (6,866,913)
Plus:     
Remeasurement of carrying value to redemption value   12,904,413 
Common stock subject to possible redemption  $116,725,000 

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,109,623 in cash and no cash equivalents as of March 31, 2022.

 

Marketable Securities Held in Trust Account

 

As of March 31, 2022, the Company held $116,736,920, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2022, the Company did not withdraw any interest income from the Trust Account to pay its tax obligations.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. 

 

Offering Costs associated with the Initial Public Offering

 

Offering costs consist of underwriting, legal, accounting, and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to shareholders’ deficit. Deferred underwriting commissions are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

 

Warrant Instruments

 

The Company will account for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. 

 

 10 
 

 

Net Loss per Share of Common Stock

 

The Company complies with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2022, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted income per share is the same as basic income per share for the period presented.

 

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

  

For the Three Months Ended

March 31, 2022

 
   Common Stock
Subject to
Redemption
   Non-
Redeemable
Common Stock
 
Basic and diluted net loss per common stock        
Numerator:        
Allocation of net loss, as adjusted  $(230,560)  $(57,640)
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
Basic and diluted net loss per common stock  $(0.02)  $(0.02)

 

Income Taxes

 

The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. 

 

The Company assesses its income tax positions and records tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances, and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, the Company’s policy is to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022.

 

The Company expects to file a U.S. federal tax return. The Company was formed in 2021 and has not been required to file any tax returns. All tax periods since inception remain open to examination by the taxing jurisdictions to which the Company is subject. 

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2022 and the adoption did not have an impact on its financial position, results of operations or cash flows.

 

 11 
 

 

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

 

Note 3 — Initial Public Offering

 

On December 20, 2021, the Company consummated its IPO of 10,000,000 Units at a purchase price of $10.00 per Unit. Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant. Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment (see Note 7). On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000

 

Following the closing of the IPO on December 20, 2021, $116,725,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the Trust Account. This amount was comprised of $10.15 per Unit for the 11,500,000 Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $116,725,000 ($10.15 per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. 

 

Note 4 — Private Placement

 

Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 6,500,000 Private Placement Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021), each exercisable to purchase one share of Common Stock at $11.50 per share, at a price of $1.00 per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000

 

The Private Placement Warrants are not transferable, assignable or salable (and the shares of Common Stock issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination).

 

If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the Public Offering. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants requires a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.

 

Note 5 — Related Party Transactions

 

Founder Shares

 

On February 23, 2021, the Company issued the Sponsor an aggregate of 2,875,000 shares of the Company’s common stock, par value $0.001 per share (the “Founder Shares”) for an aggregate purchase price of $25,000. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property.

 

 12 
 

 

Private Placement Warrants

 

The Sponsor purchased an aggregate of 7,100,000 Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $1.00 per warrant, for an aggregate purchase price of $7,100,000. Each Private Placement Warrant is identical to the Public Warrants, except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Initial Public Offering.

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). The terms of the Working Capital Loans have not been determined nor have any written agreements been executed with respect thereto. The Working Capital Loan totaling $366,000 was repaid out of the offering proceeds not held in the Trust Account. As of March 31, 2022 and December 31, 2021, the Working Capital Loans were repaid in full. 

 

Administrative Services Agreement

 

The Company’s Sponsor through the earlier of the Company’s consummation of a Business Combination and its liquidation, makes available to the Company certain general and administrative services, including office space, utilities, and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $10,000 per month for these services. The Company incurred $30,000 in operating cost associated with the administrative service fees for the three months ended March 31, 2022.

 

Note 6 — Commitments and Contingencies

 

In the course of normal operations, the Company may be involved in various claims and litigation that management intends to defend. The range of loss, if any, from potential claims cannot be reasonably estimated. 

 

Registration and Shareholder Rights

 

The holders of the Founder Shares, Public Warrants, and Private Placement Warrants that may be issued upon conversion of Working Capital Loans (and any shares of Common Stock issuable upon the exercise of the Private Placement Warrants, including those issued upon conversion of the working capital loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that no sales of these securities will be effected until after the expiration of the applicable lock-up period, as described herein. The Company will bear the expenses incurred in connection with the filing of any such registration statements. 

 

Underwriting Agreement

 

The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 1,500,000 Units to cover over-allotments if any. On December 20, 2021, the underwriters fully exercised the over-allotment option. 

 

The underwriters were paid at the closing of the IPO an underwriting commission of $0.25 per Unit sold in the IPO or $2,513,333. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $375,000 for an aggregate of $2,888,333 in underwriting commissions related to the IPO and over-allotment.

 

In addition, $3,000,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $450,000 for an aggregate of $3,450,000 in deferred underwriting commissions related to the IPO and over-allotment. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. 

 

 13 
 

 

Note 7 — Stockholders’ Equity

 

Preferred Stock

 

The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.001 and with such designations, voting, and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2022, there were no preferred shares issued or outstanding. 

 

Common Stock

 

The Company is authorized to issue 100,000,000 shares of Common Stock with a par value of $0.001 per share. As of March 31, 2022, there were 2,875,000 shares of Common Stock outstanding, excluding 11,500,000 shares of Common Stock subject to possible redemption issued.

 

Founder Shares

 

On February 23, 2021, the Sponsor purchased the 2,875,000 Founder Shares for an aggregate price of $25,000.

 

The holders of the Founder Shares will agree, subject to limited exceptions, not to transfer, assign or sell their Founder Shares, for a period ending on the date that is the earlier of (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property.

 

Public Warrants and Private Placement Warrants

 

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants were issued upon separation of the Units and only whole Public Warrants trade. The Public Warrants will become exercisable on the later of (a) one year after the date that the registration statement for the offering is declared effective by the SEC and (b) the consummation of a Business Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available.

 

The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.

 

If a registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is not effective by the 60th business day following the consummation of the Company’s initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

 

 14 
 

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

in whole and not in part;

 

at a price of $0.01 per warrant;

 

upon not less than 30 days prior written notice of redemption given after the warrants become exercisable (the “30-day redemption period”) to each warrant holder; and

 

if, and only if, the reported last sale price of the Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three days before the Company sends the notice of redemption to the warrant holders.

 

The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Common Stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of Common Stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares of Common Stock under the blue sky laws of the state of residence in those states in which the warrants were offered by the Company in the Public Offering.

 

If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the Company’s management will consider, among other factors, its cash position, the number of outstanding warrants and the dilutive effect on the Company’s stockholders of issuing the maximum number of shares of Common Stock issuable upon the exercise of the Company’s warrants. In such an event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

 

The Sponsor purchased an aggregate of 7,100,000 Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $1.00 per warrant, for an aggregate purchase price of $7,100,000. Each Private Placement Warrant is identical to the Public Warrants except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering. The Company’s initial stockholders have agreed to waive their redemption rights with respect to any Founder Shares or Private Placement Warrants (i) in connection with the consummation of a Business Combination, (ii) in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of its obligation to allow redemption in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto, to redeem 100% of the Company’s Public Shares if the Company does not consummate its initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) if the Company fails to consummate a Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or if the Company liquidates prior to the expiration of the 12-month period (or 15-month period or 18-month period, as applicable). However, the Company’s initial stockholders will be entitled to redemption rights with respect to any Public Shares held by them if the Company fails to consummate a Business Combination or liquidate within the 12-month period (or 15-month period or 18-month period, as applicable).

 

 15 
 

 

All warrants meet the requirements for equity classification and the Company accounts for the warrants as equity instruments in accordance with ASC 815, "Derivatives and Hedging", effective with the Public Offering.

 

Note 8 - Fair Value Measurements

 

Fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

Level 3, is defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

   March 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2022   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $116,736,920   $116,736,920   $-   $- 
Total  $116,736,920   $116,736,920   $-   $- 

 

   December 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2021   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $116,725,166   $116,725,166   $-   $- 
Total  $116,725,166   $116,725,166   $-   $- 

 

There were no transfers between Levels 1, 2 or 3 from inception to December 31, 2021 and during the three months ended March 31, 2022.

 

Note 9 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statement.

 

 16 
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References to the “Company,” “Ault Disruptive Technologies Corporation “our,” “us” or “we” refer to Ault Disruptive Technologies Corporation. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

 

Overview

 

We are a newly-organized blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination throughout this Annual Report. While our efforts to identify a target business may span many industries and regions worldwide, we are likely to focus our search for prospects within the technology sector, which has experienced significant disruption from new and emerging products and services. We have not yet selected any specific business combination target, although we have had substantive discussions with at least one business combination target. We intend to effectuate our initial business combination using cash from the proceeds of the Initial Public Offering and the sale of the Placement Warrants, the proceeds of the sale of our shares in connection with our initial Business Combination (including pursuant to backstop agreements we may enter into), shares issued to the owners of the target, debt issued to the bank or other lenders or the owners of the target, or a combination of the foregoing.

 

While we may pursue an initial Business Combination opportunity in any business, industry, sector or geographical location, we intend to focus on opportunities to acquire companies with innovative and emerging technologies, products or services that have the potential to transform major industries and radically impact society. We intend to acquire a target business or businesses with disruptive technologies that our management team believes can achieve mainstream adoption and create opportunities for long-term appreciation in value.

 

We are not prohibited from pursuing an initial Business Combination with a business that is owned by the Sponsor or any of the related companies or making the acquisition through a joint venture or other form of shared ownership with any of them.

 

On December 20, 2021, we consummated our IPO of 10,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one share of common stock, par value of $0.001 per share (the “Common Stock”), and three-fourths of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share. On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000. 

 

Simultaneously with the consummation of the IPO, we consummated the private placement of 6,500,000 warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor, at a price of $1.00 per Private Placement Warrant in a private placement. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000. 

 

 17 
 

 

If we are unable to consummate our initial Business Combination within such 12-month period (or 15-month period or 18-month period, as applicable), we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to us to pay our taxes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) above to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to consummate our initial business combination within the 12-month time period (or 15-month period or 18-month period, as applicable).

 

We cannot assure you that our plans to complete our initial Business Combination will be successful.

 

Results of Operations

 

Our entire activity since inception up to March 31, 2022, relates to our formation, the Initial Public Offering and since the closing of the Initial Public Offering, a search for a Business Combination candidate. We will not be generating any operating revenues until the closing and completion of our initial Business Combination, at the earliest.

 

For the three months ended March 31, 2022, we had a net loss of $288,200, which consisted of $296,891 in formation and operating costs and $3,063 of interest expense associated with our financing of our directors and officer’s insurance policy, offset by $11,754 in interest earned on marketable securities held in the Trust Account.

 

Liquidity and Capital Resources

 

As of March 31, 2022, we had $1,109,623 in our operating bank account, and working capital of $1,092,763.

 

Prior to the completion of the Initial Public Offering, our liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000, to cover certain offering costs, for the founder shares, and the loan under an unsecured promissory note from the Sponsor of $1,500,000. Subsequent to the consummation of the Initial Public Offering and Private Placement, our liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account.

 

In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us with Working Capital Loans. To date, there were no Working Capital Loans.

 

Based on the foregoing, we may need to raise additional capital through loans or additional investments from our sponsor, stockholders, officers, directors, or third parties. Our officers, directors and our sponsor may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. We will provide our public stockholders with the opportunity to redeem all or a portion of their shares of our common stock upon the consummation of our initial business combination, subject to the limitations described herein. In addition, if we are unable to consummate our initial business combination within 12 months following the effectiveness of the Initial Public Offering, which is December 15, 2022, we may, but are not obligated to, extend the period of time to complete an initial business combination up to two times by an additional three months each time (for a total of up to 18 months to consummate an initial business combination). If the period of time is not extended, we will be required to cease all operations except for the purpose of winding up. These conditions raise substantial doubt about our ability to continue as a going concern for at least one year from the date that the financial statements included in this Report were issued. The financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

 

 18 
 

 

JOBS Act

 

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

 

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company”, we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of the IPO or until we are no longer an “emerging growth company,” whichever is earlier.

 

Critical Accounting Policies

 

Management’s discussion and analysis of our results of operations and liquidity and capital resources are based on our unaudited condensed financial information. We describe our significant accounting policies in Note 2 - Significant Accounting Policies, of the Notes to Financial Statements included in this report. Our unaudited condensed financial statements have been prepared in accordance with U.S. GAAP. Certain of our accounting policies require that management apply significant judgments in defining the appropriate assumptions integral to financial estimates. On an ongoing basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP. Judgments are based on historical experience, terms of existing contracts, industry trends and information available from outside sources, as appropriate. However, by their nature, judgments are subject to an inherent degree of uncertainty, and, therefore, actual results could differ from our estimates.

We have identified the following as our critical accounting policies:

 

Common Stock Subject to Possible Redemption

 

We account for our shares of common stock subject to possible redemption in accordance with the guidance in accounting standards codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, the common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ deficit section of our audited balance sheet.

 

Net Loss per Share of Common Stock

 

We comply with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2022, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted income per share is the same as basic income per share for the period presented.

 

Derivatives

 

We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period.

 

 19 
 

 

We accounted for the 8,625,000 Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to our common stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of our control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

All activity from February 22, 2021 (date of inception) through March 31, 2022, relates to our formation, the preparation for our IPO, and the search of targets for our initial Business Combination. We did not have any financial instruments that were exposed to market risks on March 31, 2022.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our chief executive officer and chief financial officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective.

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes to our internal control over financial reporting that occurred during our fiscal quarter ended March 31, 2022 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 

 20 
 

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.

 

Item 1A. Risk Factors.

 

As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Use of Proceeds

 

On December 20, 2021, we sold 11,500,000 units, including 1,500,000 units pursuant to the exercise of the underwriters’ over-allotment option in full, at a purchase price of $10.00 per unit in our initial public offering (the “IPO”). Simultaneously with the closing of the IPO, we consummated the private placement of 7,100,000 private warrants for an aggregate purchase price of $7,100,000 (the “Private Placement”). Following the closing of the IPO and the Private Placement on December 20, 2021, $116,725,000 from the net proceeds of the sale of the units in the IPO and the sale of the private placement units was deposited into our trust account (the “Trust Account”), and $1,849,679 of cash was held outside of the Trust Account and is available for the Company’s working capital purposes. Transaction costs amounted to $7,087,891 in transaction costs, including $6,338,333 of underwriting fees ($3,450,000 consisted of deferred underwriting fees) and $749,558 of other costs.

 

The net proceeds deposited into the Trust Account are invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.

 

There has been no material change in the planned use of the proceeds from the Initial Public Offering and Private Placement as is described in our final prospectus dated December 15, 2021 and filed with the SEC on December 16, 2021.

 

Item 3.Defaults Upon Senior Securities.

 

None.

 

Item 4.Mine Safety Disclosures.

 

Not Applicable.

 

Item 5.Other Information.

 

Not Applicable.

 

 21 
 

 

Item 6.Exhibits.

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit   Description
     
3.1   Certification of Incorporation. Incorporated herein by reference to the Registration Statement on Form S-1 filed on November 5, 2021, as Exhibit 3.1 thereto.  
     
3.2    Amended and Restated Certificate of Incorporation. Incorporated herein by reference to the Current Report on Form 8-K filed on December 20, 2021, as Exhibit 3.1 thereto.
     
3.3   By-Laws. Incorporated herein by reference to the Registration Statement on Form S-1 filed on November 5, 2021, as Exhibit 3.3 thereto.
     
31.1*   Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
     
31.2*   Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
     
32.1**   Certification of the Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code.
     
101.INS*   XBRL Instance Document.  The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
     
101.SCH*   XBRL Taxonomy Extension Schema Document
     
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document
     
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*Filed herewith.
**Furnished herewith.

 

 22 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    Ault Disruptive Technologies Corporation  
Dated: May 23, 2022   /s/ William B. Horne  
    William B. Horne  
    Chief Executive Officer  
    (Principal Executive Officer)  
       
Dated: May 23, 2022   /s/ Kenneth S. Cragun  
    Kenneth S. Cragun  
    Chief Financial Officer  
    (Principal Financial and Accounting Officer)  

 

 

23

 

 

 

 

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

 

EXHIBIT 31.1

CERTIFICATION

 

I, William B. Horne, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Q of Ault Disruptive Technologies Corporation;

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated:  May 23, 2022

 

/s/ William B. Horne  
Name: William B. Horne  
Title: Chief Executive Officer  
(Principal Executive Officer)  

 

 

 

 

 

 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

 

EXHIBIT 31.2

CERTIFICATION

 

I, Kenneth S. Cragun, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Q of Ault Disruptive Technologies Corporation;

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated:  May 23, 2022

 

/s/ Kenneth S. Cragun  
Name: Kenneth S. Cragun  
Title: Chief Financial Officer  
(Principal Accounting Officer)  

 

 

 

 

 

 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Ault Disruptive Technologies Corporation (the “Company”) on Form 10-Q for the period ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: May 23, 2022  
   
   
  By: /s/ William B. Horne
  Name: William B. Horne
  Title: Chief Executive Officer
   (Principal Executive Officer)

 

Date: May 23, 2022  
   
   
  By: /s/ Kenneth S. Cragun
  Name: Kenneth S. Cragun
  Title: Chief Financial Officer
   (Principal Accounting Officer)

 

 

 

 

 

 

EX-101.SCH 5 adrt-20220331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED BALANCE SHEETS (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED BALANCE SHEETS (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Business Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Initial Public Offering link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Private Placement link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Organization and Business Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table: (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts): (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Initial Public Offering (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Private Placement (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determi (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 adrt-20220331_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 adrt-20220331_def.xml XBRL DEFINITION FILE EX-101.LAB 8 adrt-20220331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.001 par value Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Sale of Stock [Axis] IPO [Member] Private Placement [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Over-Allotment Option [Member] Related Party [Axis] Sponsor [Member] Private Placement 1 [Member] Private Placement 2 [Member] Founder Shares [Member] Cash and Cash Equivalents [Axis] Money Market Funds [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current asset - cash Prepaid expenses Total current assets Prepaid expenses, non-current Cash and securities held in Trust Account Total Assets Liabilities and Stockholders’ Equity Current liabilities: Accounts payable Accrued offering costs and expenses Total current liabilities Deferred underwriting commissions Total liabilities Commitments Common stock subject to possible redemption, 11,500,000 shares at redemption value Stockholders’ Deficit: Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued and outstanding Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding Additional paid-in capital Accumulated deficit Total stockholders’ deficit Total Liabilities and Stockholders’ Deficit Common stock, shares authorized redemption Preferred stock, par value (in dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value (in dollars per share) Common stock, shares authorized Common stock, shares, issued Common stock, shares, outstanding Income Statement [Abstract] Formation and operating costs Loss from operations Other income Trust interest income Interest expense Income from investments held in trust account Total other income Net loss Basic and diluted weighted average shares outstanding, common stock subject to redemption Basic and diluted net income per share attributable to common stock subject to redemption Basic and diluted weighted average shares outstanding, common stock Basic and diluted net loss per share attributable to common stockholders Balance as of February 22, 2021 (inception) Balance at beginning (in shares) Net loss Issuance of common stock to sponsor Issuance of common stock to sponsor (in shares) Ending balance, value Balance, end (in shares) Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Adjustments to reconcile net loss to net cash used in operating activities: Interest earned on Trust Account Income from investments held in Trust Account Changes in current assets and current liabilities: Prepaid expenses Accrued offering costs and expenses Net cash used in operating activities Cash Flows from Investing Activities: Net cash used in investing activities Cash Flows from Financing Activities: Payments of offering costs Net cash used in financing activities Net change in cash Cash, beginning of the period Cash, end of the period Supplemental disclosure of noncash investing and financing activities: Deferred offering costs included in accrued offering costs and accounts payable Payment of deferred offering costs by the Sponsor in exchange for the issuance of common stock Organization And Business Operations Organization and Business Operations Accounting Policies [Abstract] Summary of Significant Accounting Policies Initial Public Offering Initial Public Offering Private Placement Private Placement Related Party Transactions [Abstract] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Stockholders’ Equity Fair Value Disclosures [Abstract] Fair Value Measurements Subsequent Events [Abstract] Subsequent Events Basis of Presentation Emerging Growth Company Status Use of Estimates Accounting Policy on Redeemable Shares Cash and Cash Equivalents Marketable Securities Held in Trust Account Concentration of Credit Risk Fair Value of Financial Instruments Offering Costs associated with the Initial Public Offering Warrant Instruments Net Loss per Share of Common Stock Income Taxes Recent Accounting Pronouncements As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table: The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts): The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Issuance of common stock to Sponsors (in shares) Sale of stock, price per share Stock Issued During Period, Shares, New Issues Description of stock issuance Proceeds from Issuance of Common Stock Transaction cost Offering cost cash held from out side Stock issued during period new issues Cash Working capital Gross proceeds Proceeds allocated to Public Warrants Issuance costs allocated to common stock Remeasurement of carrying value to redemption value Common stock subject to possible redemption Allocation of net loss, as adjusted redeemable Allocation of net loss, as adjusted non redeemable Basic and diluted weighted average shares outstanding redeemable Basic and diluted weighted average shares outstanding non redeemable Basic and diluted net loss per common stock redemable Basic and diluted net loss per common stock non redemable [custom:CommonStockSharesAuthorizedRedemption-0] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Stock Issued During Period, Shares, New Issues Shares purchase price (in dollars per share) Sale of stock, description of transaction Issuance of common stock to sponsors (in shares) Proceeds from issuance of private placement warrants Share price per unit Share price per unit Exercise price per share [custom:SaleOfStockPricePerShare1-0] Proceeds from option exercise Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Shares issued for services Common Stock, Par or Stated Value Per Share Aggregate purchase price Common stock par or stated value per share Underwriting fees Exercise price (in dollars per share) Warrant terms Working capital loan Sponsor fees Operating cost Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Preferred Stock, Par or Stated Value Per Share Class of warrant or right, expense or revenue recognized Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Total assets Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Income (Loss) Interest Expense Nonoperating Income (Expense) InterestIncome Increase (Decrease) in Prepaid Expenses, Other Costs and Expenses PaymentOfOfferingCosts Cash and Cash Equivalents, at Carrying Value InitialPublicOffering PrivatePlacement StockIssuedDuringPeriodSharesNewIssuesOne EX-101.PRE 9 adrt-20220331_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - shares
3 Months Ended
Mar. 31, 2022
May 13, 2022
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41171  
Entity Registrant Name AULT DISRUPTIVE TECHNOLOGIES CORPORATION  
Entity Central Index Key 0001864032  
Entity Tax Identification Number 86-2279256  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 11411 Southern Highlands Pkwy  
Entity Address, Address Line Two Suite 240  
Entity Address, City or Town Las Vegas  
Entity Address, State or Province NV  
Entity Address, Postal Zip Code 89141  
City Area Code (949)  
Local Phone Number 444-5464  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company true  
Entity Common Stock, Shares Outstanding   2,875,000
Common Stock, $0.001 par value    
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol ADRT  
Security Exchange Name NYSEAMER  
Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50    
Title of 12(b) Security Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50  
Trading Symbol ADRTW  
Security Exchange Name NYSEAMER  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED BALANCE SHEETS (unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Assets    
Current asset - cash $ 1,109,623 $ 1,849,679
Prepaid expenses 419,817 395,000
Total current assets 1,529,440 2,244,679
Prepaid expenses, non-current 293,582 375,000
Cash and securities held in Trust Account 116,736,920 116,725,166
Total Assets 118,559,942 119,344,845
Current liabilities:    
Accounts payable 80,659 173,390
Accrued offering costs and expenses 356,018 759,990
Total current liabilities 436,677 933,380
Deferred underwriting commissions 3,450,000 3,450,000
Total liabilities 3,886,677 4,383,380
Common stock subject to possible redemption, 11,500,000 shares at redemption value 116,725,000 116,725,000
Stockholders’ Deficit:    
Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding 2,875 2,875
Additional paid-in capital
Accumulated deficit (2,054,610) (1,766,410)
Total stockholders’ deficit (2,051,735) (1,763,535)
Total Liabilities and Stockholders’ Deficit $ 118,559,942 $ 119,344,845
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED BALANCE SHEETS (unaudited) (Parenthetical) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Common stock, shares authorized redemption 11,500,000 11,500,000
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares, issued 2,875,000 2,875,000
Common stock, shares, outstanding 2,875,000 2,875,000
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
1 Months Ended 3 Months Ended
Mar. 31, 2021
Mar. 31, 2022
Income Statement [Abstract]    
Formation and operating costs $ 958 $ 296,891
Loss from operations (958) (296,891)
Other income    
Trust interest income
Interest expense (3,063)
Income from investments held in trust account 11,754
Total other income 8,691
Net loss $ (958) $ (288,200)
Basic and diluted weighted average shares outstanding, common stock subject to redemption 11,500,000
Basic and diluted net income per share attributable to common stock subject to redemption $ (0.02)
Basic and diluted weighted average shares outstanding, common stock 2,500,000 2,875,000
Basic and diluted net loss per share attributable to common stockholders $ (0.00) $ (0.02)
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance as of February 22, 2021 (inception) at Feb. 22, 2021
Balance at beginning (in shares) at Feb. 22, 2021      
Net loss (958) (958)
Issuance of common stock to sponsor $ 2,875 22,125 25,000
Issuance of common stock to sponsor (in shares) 2,875,000      
Ending balance, value at Mar. 31, 2021 $ 2,875 22,125 (958) 24,052
Balance, end (in shares) at Mar. 31, 2021 2,875,000      
Balance as of February 22, 2021 (inception) at Dec. 31, 2021 $ 2,875 (1,766,410) $ (1,763,535)
Balance at beginning (in shares) at Dec. 31, 2021 2,875,000     2,875,000
Net loss (288,200) $ (288,200)
Ending balance, value at Mar. 31, 2022 $ 2,875 $ (2,054,610) $ (2,051,735)
Balance, end (in shares) at Mar. 31, 2022 2,875,000     2,875,000
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
1 Months Ended 3 Months Ended
Mar. 31, 2021
Mar. 31, 2022
Cash Flows from Operating Activities:    
Net loss $ (958) $ (288,200)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest earned on Trust Account
Income from investments held in Trust Account (11,754)
Changes in current assets and current liabilities:    
Prepaid expenses 56,601
Accrued offering costs and expenses 958 (346,067)
Net cash used in operating activities (589,420)
Cash Flows from Investing Activities:    
Net cash used in investing activities
Cash Flows from Financing Activities:    
Payments of offering costs (150,636)
Net cash used in financing activities (150,636)
Net change in cash (740,056)
Cash, beginning of the period 1,849,679
Cash, end of the period 1,109,623
Supplemental disclosure of noncash investing and financing activities:    
Deferred offering costs included in accrued offering costs and accounts payable 54,033
Payment of deferred offering costs by the Sponsor in exchange for the issuance of common stock $ 25,000
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Organization and Business Operations
3 Months Ended
Mar. 31, 2022
Organization And Business Operations  
Organization and Business Operations

Note 1 — Organization and Business Operations

 

Organization and General

 

Ault Disruptive Technologies Corporation (the “Company”) is a blank check company organized on February 22, 2021, under the laws of the State of Delaware. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies with innovative and emerging technologies, products or services in the United States.

 

As of March 31, 2022, the Company had not commenced any operations. All activity for the period from February 22, 2021 (inception) through March 31, 2022, relates to the Company’s formation, the public offering described below and the search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering (the “IPO” or “Public Offering”). The Company has selected December 31 as its fiscal year end.

 

The Company’s Sponsor is Ault Disruptive Technologies Company, LLC (the “Sponsor”).

 

Financing 

 

The registration statement for the Company’s IPO was declared effective on December 15, 2021 (the “Effective Date”). On December 20, 2021, the Company consummated its IPO of 10,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one share of common stock, par value of $0.001 per share (the “Common Stock”), and three-fourths of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share. On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000. 

 

Simultaneously with the consummation of the IPO, the Company consummated the private placement of 6,500,000 warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor, at a price of $1.00 per Private Placement Warrant in a private placement. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000

 

Transaction costs related to the IPO amounted to $6,297,333 consisting of $2,513,333 of underwriting commissions, $3,000,000 of deferred underwriting commissions, and $784,000 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $7,122,333 consisting of $2,888,333 of underwriting commissions, $3,450,000 of deferred underwriting commissions, and $784,000 of other offering costs. In addition, $1,109,623 of cash was held outside of the Trust Account (as defined below) as of March 31, 2022 and is available for working capital purposes.

 

Initial Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

 

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

 

Trust Account

 

Following the closing of the IPO on December 20, 2021, $116,725,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.15 per Unit for the 11,500,000 Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $116,725,000 was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The trust account is intended as a holding place for funds pending the earliest to occur of: (i) the consummation of the Company’s initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation (A) to modify the substance or timing of its obligation to allow redemptions in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto or to redeem 100% of the Company’s public shares if the Company does not consummate its initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering, the Company’s return of the funds held in the trust account to its public stockholders as part of its redemption of the public shares. If the Company does not invest the proceeds as discussed above, the Company may be deemed to be subject to the Investment Company Act. If the Company is deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which the Company has not allotted funds and may hinder its ability to consummate an initial Business Combination or may result in its liquidation. If the Company is unable to consummate its initial Business Combination, the Company’s public stockholders may receive only approximately $10.15 per public share, or $10.25 or $10.35 per public share, as applicable, on the liquidation of the Company’s trust account and its warrants will expire worthlessly.

 

The Company will provide holders (the “Public Shareholders”) of its Common Stock sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely at its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement.

 

The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Common Stock upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is currently anticipated to be $10.15 per public share.

 

The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close. 

 

The Common Stock subject to redemption was recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company’s amended and restated articles of incorporation provides that the Company will have only 12 months following the effectiveness of the Public Offering (or up to 18 months following the effectiveness of the Public Offering if the Company extends the period of time to consummate a Business Combination, subject to the Sponsor depositing additional funds in the Trust Account) (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $50,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period.

 

The Sponsor and each member of its management team have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (defined in Note 5), Private Placement Warrants and Public Shares held by them (ii) to waive their redemption rights with respect to their Founder Shares, Private Placement Warrants and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) that would modify the substance or timing of the Company’s obligation to provide holders of shares of Common Stock the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within Combination Period or (B) with respect to any other provision relating to the rights of holders of shares of Common Stock or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Warrants they hold if the Company fails to consummate an initial Business Combination within Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).

 

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Private Placement Warrants if the Company fails to consummate a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to consummate a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not consummate a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.15, or $10.25 or $10.35 per Public Share, as applicable). 

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.15 per Public Share, or $10.25 or $10.35 per Public Share, as applicable, and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and Going Concern

 

As of March 31, 2022, the Company had approximately $1.1 million in its operating bank account and working capital of approximately $1.1 million.

 

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

 

The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In addition, if the Company is unable to consummate the Business Combination within 12 months following the effectiveness of the Initial Public Offering, which is December 15, 2022, the Company may, but is not obligated to, extend the period of time to complete the Business Combination up to two times by an additional three months each time (for a total of up to 18 months to consummate an initial business combination). If the period of time is not extended, the Company will be required to cease all operations except for the purpose of winding up. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date that the financial statement were issued. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Risks and Uncertainties

 

The Company has a limited operating history and has not yet generated revenue from intended operations. The Company’s business and operations are sensitive to general business and economic conditions in the U.S. along with local, state, and federal government policy decisions. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including but not limited to, credit risk, and changes to regulations governing the Company’s industry. Adverse developments in this general business and economic conditions could have a material adverse effect on the Company’s financial condition and the results of its operations. 

 

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or searching for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 15, 2022.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

 

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company intends to take advantage of the benefits of this extended transition period.

 

The Company will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the effectiveness of the Initial Public Offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.

 

Additionally, the Company is a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates equals or exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30th.  

 

Use of Estimates

 

The preparation of the financial statements are in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Accounting Policy on Redeemable Shares

 

The Company will account for its Common Stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, shares of common stock will be classified as shareholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Accordingly, 11,500,000 shares of Common Stock are subject to possible redemption, which are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. 

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid-in capital and accumulated deficit. 

 

As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:

 

      
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (4,312,500)
Issuance costs allocated to common stock   (6,866,913)
Plus:     
Remeasurement of carrying value to redemption value   12,904,413 
Common stock subject to possible redemption  $116,725,000 

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,109,623 in cash and no cash equivalents as of March 31, 2022.

 

Marketable Securities Held in Trust Account

 

As of March 31, 2022, the Company held $116,736,920, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2022, the Company did not withdraw any interest income from the Trust Account to pay its tax obligations.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. 

 

Offering Costs associated with the Initial Public Offering

 

Offering costs consist of underwriting, legal, accounting, and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to shareholders’ deficit. Deferred underwriting commissions are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

 

Warrant Instruments

 

The Company will account for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. 

 

Net Loss per Share of Common Stock

 

The Company complies with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2022, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted income per share is the same as basic income per share for the period presented.

 

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

  

For the Three Months Ended

March 31, 2022

 
   Common Stock
Subject to
Redemption
   Non-
Redeemable
Common Stock
 
Basic and diluted net loss per common stock        
Numerator:        
Allocation of net loss, as adjusted  $(230,560)  $(57,640)
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
Basic and diluted net loss per common stock  $(0.02)  $(0.02)

 

Income Taxes

 

The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. 

 

The Company assesses its income tax positions and records tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances, and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, the Company’s policy is to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022.

 

The Company expects to file a U.S. federal tax return. The Company was formed in 2021 and has not been required to file any tax returns. All tax periods since inception remain open to examination by the taxing jurisdictions to which the Company is subject. 

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2022 and the adoption did not have an impact on its financial position, results of operations or cash flows.

 

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

 

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Initial Public Offering
3 Months Ended
Mar. 31, 2022
Initial Public Offering  
Initial Public Offering

Note 3 — Initial Public Offering

 

On December 20, 2021, the Company consummated its IPO of 10,000,000 Units at a purchase price of $10.00 per Unit. Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant. Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment (see Note 7). On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000

 

Following the closing of the IPO on December 20, 2021, $116,725,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the Trust Account. This amount was comprised of $10.15 per Unit for the 11,500,000 Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $116,725,000 ($10.15 per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Private Placement
3 Months Ended
Mar. 31, 2022
Private Placement  
Private Placement

Note 4 — Private Placement

 

Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 6,500,000 Private Placement Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021), each exercisable to purchase one share of Common Stock at $11.50 per share, at a price of $1.00 per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000

 

The Private Placement Warrants are not transferable, assignable or salable (and the shares of Common Stock issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination).

 

If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the Public Offering. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants requires a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions
3 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
Related Party Transactions

Note 5 — Related Party Transactions

 

Founder Shares

 

On February 23, 2021, the Company issued the Sponsor an aggregate of 2,875,000 shares of the Company’s common stock, par value $0.001 per share (the “Founder Shares”) for an aggregate purchase price of $25,000. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property.

 

Private Placement Warrants

 

The Sponsor purchased an aggregate of 7,100,000 Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $1.00 per warrant, for an aggregate purchase price of $7,100,000. Each Private Placement Warrant is identical to the Public Warrants, except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Initial Public Offering.

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). The terms of the Working Capital Loans have not been determined nor have any written agreements been executed with respect thereto. The Working Capital Loan totaling $366,000 was repaid out of the offering proceeds not held in the Trust Account. As of March 31, 2022 and December 31, 2021, the Working Capital Loans were repaid in full. 

 

Administrative Services Agreement

 

The Company’s Sponsor through the earlier of the Company’s consummation of a Business Combination and its liquidation, makes available to the Company certain general and administrative services, including office space, utilities, and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $10,000 per month for these services. The Company incurred $30,000 in operating cost associated with the administrative service fees for the three months ended March 31, 2022.

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 — Commitments and Contingencies

 

In the course of normal operations, the Company may be involved in various claims and litigation that management intends to defend. The range of loss, if any, from potential claims cannot be reasonably estimated. 

 

Registration and Shareholder Rights

 

The holders of the Founder Shares, Public Warrants, and Private Placement Warrants that may be issued upon conversion of Working Capital Loans (and any shares of Common Stock issuable upon the exercise of the Private Placement Warrants, including those issued upon conversion of the working capital loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that no sales of these securities will be effected until after the expiration of the applicable lock-up period, as described herein. The Company will bear the expenses incurred in connection with the filing of any such registration statements. 

 

Underwriting Agreement

 

The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 1,500,000 Units to cover over-allotments if any. On December 20, 2021, the underwriters fully exercised the over-allotment option. 

 

The underwriters were paid at the closing of the IPO an underwriting commission of $0.25 per Unit sold in the IPO or $2,513,333. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $375,000 for an aggregate of $2,888,333 in underwriting commissions related to the IPO and over-allotment.

 

In addition, $3,000,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $450,000 for an aggregate of $3,450,000 in deferred underwriting commissions related to the IPO and over-allotment. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. 

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Stockholders’ Equity

Note 7 — Stockholders’ Equity

 

Preferred Stock

 

The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.001 and with such designations, voting, and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2022, there were no preferred shares issued or outstanding. 

 

Common Stock

 

The Company is authorized to issue 100,000,000 shares of Common Stock with a par value of $0.001 per share. As of March 31, 2022, there were 2,875,000 shares of Common Stock outstanding, excluding 11,500,000 shares of Common Stock subject to possible redemption issued.

 

Founder Shares

 

On February 23, 2021, the Sponsor purchased the 2,875,000 Founder Shares for an aggregate price of $25,000.

 

The holders of the Founder Shares will agree, subject to limited exceptions, not to transfer, assign or sell their Founder Shares, for a period ending on the date that is the earlier of (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property.

 

Public Warrants and Private Placement Warrants

 

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants were issued upon separation of the Units and only whole Public Warrants trade. The Public Warrants will become exercisable on the later of (a) one year after the date that the registration statement for the offering is declared effective by the SEC and (b) the consummation of a Business Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available.

 

The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.

 

If a registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is not effective by the 60th business day following the consummation of the Company’s initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

in whole and not in part;

 

at a price of $0.01 per warrant;

 

upon not less than 30 days prior written notice of redemption given after the warrants become exercisable (the “30-day redemption period”) to each warrant holder; and

 

if, and only if, the reported last sale price of the Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three days before the Company sends the notice of redemption to the warrant holders.

 

The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Common Stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of Common Stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares of Common Stock under the blue sky laws of the state of residence in those states in which the warrants were offered by the Company in the Public Offering.

 

If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the Company’s management will consider, among other factors, its cash position, the number of outstanding warrants and the dilutive effect on the Company’s stockholders of issuing the maximum number of shares of Common Stock issuable upon the exercise of the Company’s warrants. In such an event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

 

The Sponsor purchased an aggregate of 7,100,000 Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $1.00 per warrant, for an aggregate purchase price of $7,100,000. Each Private Placement Warrant is identical to the Public Warrants except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering. The Company’s initial stockholders have agreed to waive their redemption rights with respect to any Founder Shares or Private Placement Warrants (i) in connection with the consummation of a Business Combination, (ii) in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of its obligation to allow redemption in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto, to redeem 100% of the Company’s Public Shares if the Company does not consummate its initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) if the Company fails to consummate a Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or if the Company liquidates prior to the expiration of the 12-month period (or 15-month period or 18-month period, as applicable). However, the Company’s initial stockholders will be entitled to redemption rights with respect to any Public Shares held by them if the Company fails to consummate a Business Combination or liquidate within the 12-month period (or 15-month period or 18-month period, as applicable).

 

All warrants meet the requirements for equity classification and the Company accounts for the warrants as equity instruments in accordance with ASC 815, "Derivatives and Hedging", effective with the Public Offering.

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 8 - Fair Value Measurements

 

Fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

Level 3, is defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

   March 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2022   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $116,736,920   $116,736,920   $-   $- 
Total  $116,736,920   $116,736,920   $-   $- 

 

   December 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2021   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $116,725,166   $116,725,166   $-   $- 
Total  $116,725,166   $116,725,166   $-   $- 

 

There were no transfers between Levels 1, 2 or 3 from inception to December 31, 2021 and during the three months ended March 31, 2022.

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note 9 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statement.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 15, 2022.

Emerging Growth Company Status

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

 

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company intends to take advantage of the benefits of this extended transition period.

 

The Company will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the effectiveness of the Initial Public Offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.

 

Additionally, the Company is a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates equals or exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30th.  

Use of Estimates

Use of Estimates

 

The preparation of the financial statements are in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Accounting Policy on Redeemable Shares

Accounting Policy on Redeemable Shares

 

The Company will account for its Common Stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, shares of common stock will be classified as shareholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Accordingly, 11,500,000 shares of Common Stock are subject to possible redemption, which are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. 

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid-in capital and accumulated deficit. 

 

As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:

 

      
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (4,312,500)
Issuance costs allocated to common stock   (6,866,913)
Plus:     
Remeasurement of carrying value to redemption value   12,904,413 
Common stock subject to possible redemption  $116,725,000 

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,109,623 in cash and no cash equivalents as of March 31, 2022.

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

 

As of March 31, 2022, the Company held $116,736,920, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2022, the Company did not withdraw any interest income from the Trust Account to pay its tax obligations.

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. 

Offering Costs associated with the Initial Public Offering

Offering Costs associated with the Initial Public Offering

 

Offering costs consist of underwriting, legal, accounting, and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to shareholders’ deficit. Deferred underwriting commissions are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Warrant Instruments

Warrant Instruments

 

The Company will account for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. 

Net Loss per Share of Common Stock

Net Loss per Share of Common Stock

 

The Company complies with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2022, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted income per share is the same as basic income per share for the period presented.

 

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

  

For the Three Months Ended

March 31, 2022

 
   Common Stock
Subject to
Redemption
   Non-
Redeemable
Common Stock
 
Basic and diluted net loss per common stock        
Numerator:        
Allocation of net loss, as adjusted  $(230,560)  $(57,640)
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
Basic and diluted net loss per common stock  $(0.02)  $(0.02)

 

Income Taxes

Income Taxes

 

The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. 

 

The Company assesses its income tax positions and records tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances, and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, the Company’s policy is to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022.

 

The Company expects to file a U.S. federal tax return. The Company was formed in 2021 and has not been required to file any tax returns. All tax periods since inception remain open to examination by the taxing jurisdictions to which the Company is subject. 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2022 and the adoption did not have an impact on its financial position, results of operations or cash flows.

 

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:

As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:

 

      
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (4,312,500)
Issuance costs allocated to common stock   (6,866,913)
Plus:     
Remeasurement of carrying value to redemption value   12,904,413 
Common stock subject to possible redemption  $116,725,000 
The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

  

For the Three Months Ended

March 31, 2022

 
   Common Stock
Subject to
Redemption
   Non-
Redeemable
Common Stock
 
Basic and diluted net loss per common stock        
Numerator:        
Allocation of net loss, as adjusted  $(230,560)  $(57,640)
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
Basic and diluted net loss per common stock  $(0.02)  $(0.02)
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

   March 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2022   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $116,736,920   $116,736,920   $-   $- 
Total  $116,736,920   $116,736,920   $-   $- 

 

   December 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2021   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $116,725,166   $116,725,166   $-   $- 
Total  $116,725,166   $116,725,166   $-   $- 
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Organization and Business Operations (Details Narrative) - USD ($)
3 Months Ended
Dec. 20, 2021
Dec. 20, 2021
Dec. 15, 2021
Mar. 31, 2022
Subsidiary, Sale of Stock [Line Items]        
Proceeds from Issuance of Common Stock       $ 7,100,000
cash held from out side       1,109,623
Cash       1,100,000
Working capital       1,100,000
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Transaction cost       6,297,333
Offering cost       784,000
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Issuance of common stock to Sponsors (in shares) 116,725,000   10,000,000  
Sale of stock, price per share $ 10.15 $ 10.15 $ 10.00  
Private Placement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Issuance of common stock to Sponsors (in shares) 6,500,000      
Sale of stock, price per share $ 10.15 $ 10.15    
Stock Issued During Period, Shares, New Issues 6,500,000      
Description of stock issuance warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor      
Proceeds from Issuance of Common Stock $ 7,100,000      
Stock issued during period new issues 11,500,000      
Over-Allotment Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Issuance of common stock to Sponsors (in shares) 116,725,000 11,500,000    
Proceeds from Issuance of Common Stock   $ 115,000,000    
Transaction cost       7,122,333
Offering cost       $ 784,000
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.1
As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table: (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
Accounting Policies [Abstract]  
Gross proceeds $ 115,000,000
Proceeds allocated to Public Warrants (4,312,500)
Issuance costs allocated to common stock (6,866,913)
Remeasurement of carrying value to redemption value 12,904,413
Common stock subject to possible redemption $ 116,725,000
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.1
The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts): (Details) - USD ($)
1 Months Ended 3 Months Ended
Mar. 31, 2021
Mar. 31, 2022
Accounting Policies [Abstract]    
Allocation of net loss, as adjusted redeemable   $ (230,560)
Allocation of net loss, as adjusted non redeemable   $ (57,640)
Basic and diluted weighted average shares outstanding redeemable 11,500,000
Basic and diluted weighted average shares outstanding non redeemable 2,500,000 2,875,000
Basic and diluted net loss per common stock redemable $ (0.02)
Basic and diluted net loss per common stock non redemable $ (0.00) $ (0.02)
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Details Narrative) - shares
Mar. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
[custom:CommonStockSharesAuthorizedRedemption-0] 11,500,000 11,500,000
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Initial Public Offering (Details Narrative) - USD ($)
3 Months Ended
Dec. 20, 2021
Dec. 20, 2021
Dec. 15, 2021
Nov. 20, 2021
Mar. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from issuance of private placement warrants         $ 7,100,000
IPO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Shares purchase price (in dollars per share)       $ 10.00  
Sale of stock, description of transaction   Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant      
Issuance of common stock to sponsors (in shares) 116,725,000   10,000,000    
Share price per unit $ 10.15 $ 10.15      
Share price per unit $ 10.15 $ 10.15 $ 10.00    
Over-Allotment Option [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Issuance of common stock to sponsors (in shares) 116,725,000 11,500,000      
Proceeds from issuance of private placement warrants   $ 115,000,000      
Private Placement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sale of stock, description of transaction   Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021), each exercisable to purchase one      
Issuance of common stock to sponsors (in shares) 6,500,000        
Proceeds from issuance of private placement warrants $ 7,100,000        
Stock issued during period new issues 11,500,000        
Share price per unit $ 10.15 $ 10.15      
IPO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock Issued During Period, Shares, New Issues 10,000,000        
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Private Placement (Details Narrative) - USD ($)
3 Months Ended
Dec. 20, 2021
Dec. 20, 2021
Mar. 31, 2022
Subsidiary, Sale of Stock [Line Items]      
Proceeds from option exercise     $ 7,100,000
Private Placement [Member]      
Subsidiary, Sale of Stock [Line Items]      
Issuance of common stock to sponsors (in shares) 6,500,000    
Sale of stock, description of transaction   Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021), each exercisable to purchase one  
Exercise price per share $ 11.50 $ 11.50  
[custom:SaleOfStockPricePerShare1-0] $ 1.00 $ 1.00  
Proceeds from option exercise $ 7,100,000    
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Mar. 31, 2021
Mar. 31, 2022
Dec. 31, 2021
Feb. 23, 2021
Related Party Transaction [Line Items]        
Common Stock, Par or Stated Value Per Share   $ 0.001 $ 0.001 $ 0.001
Aggregate purchase price $ 25,000      
Common stock par or stated value per share       $ 12.00
Working capital loan   $ 366,000    
Operating cost   $ 30,000    
Private Placement [Member]        
Related Party Transaction [Line Items]        
Warrant terms   12 months    
Private Placement 1 [Member]        
Related Party Transaction [Line Items]        
Warrant terms   15 months    
Private Placement 2 [Member]        
Related Party Transaction [Line Items]        
Warrant terms   18 months    
Sponsor [Member]        
Related Party Transaction [Line Items]        
Shares issued for services 2,875,000      
Aggregate purchase price $ 25,000      
Sponsor fees   $ 10,000    
Sponsor [Member] | Private Placement [Member]        
Related Party Transaction [Line Items]        
Underwriting fees   $ 7,100,000    
Exercise price (in dollars per share)   $ 1.00    
Sponsor [Member] | Private Placement 1 [Member]        
Related Party Transaction [Line Items]        
Underwriting fees   $ 600,000    
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Feb. 23, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Preferred stock, shares issued 0 0  
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001  
Common stock, shares, issued 2,875,000 2,875,000  
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001 $ 0.001
Common stock, shares, outstanding 2,875,000 2,875,000  
Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding $ 2,875 $ 2,875 $ 25,000
Class of warrant or right, expense or revenue recognized The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price    
Private Placement [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Warrant terms 12 months    
Private Placement 1 [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Warrant terms 15 months    
Private Placement 2 [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Warrant terms 18 months    
Sponsor [Member] | Private Placement [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Underwriting fees $ 7,100,000    
Exercise price (in dollars per share) $ 1.00    
Sponsor [Member] | Private Placement 1 [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Underwriting fees $ 600,000    
Founder Shares [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Common stock, shares, issued     2,875,000
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.1
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determi (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 116,736,920 $ 116,725,166
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 116,736,920 116,725,166
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets
Money Market Funds [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 116,736,920 116,725,166
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 116,736,920 116,725,166
Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets
Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets
XML 37 adtc51022010q_htm.xml IDEA: XBRL DOCUMENT 0001864032 2022-01-01 2022-03-31 0001864032 adrt:CommonStock0.001ParValueMember 2022-01-01 2022-03-31 0001864032 adrt:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member 2022-01-01 2022-03-31 0001864032 2022-05-13 0001864032 2022-03-31 0001864032 2021-12-31 0001864032 2021-02-22 2021-03-31 0001864032 us-gaap:CommonStockMember 2021-12-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001864032 us-gaap:RetainedEarningsMember 2021-12-31 0001864032 us-gaap:CommonStockMember 2021-02-22 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-02-22 0001864032 us-gaap:RetainedEarningsMember 2021-02-22 0001864032 2021-02-22 0001864032 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001864032 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001864032 us-gaap:CommonStockMember 2021-02-23 2021-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-02-23 2021-03-31 0001864032 us-gaap:RetainedEarningsMember 2021-02-23 2021-03-31 0001864032 2021-02-23 2021-03-31 0001864032 us-gaap:CommonStockMember 2022-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001864032 us-gaap:RetainedEarningsMember 2022-03-31 0001864032 us-gaap:CommonStockMember 2021-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001864032 us-gaap:RetainedEarningsMember 2021-03-31 0001864032 2021-03-31 0001864032 2021-02-21 0001864032 us-gaap:IPOMember 2021-12-13 2021-12-15 0001864032 us-gaap:IPOMember 2021-12-15 0001864032 us-gaap:PrivatePlacementMember 2021-12-18 2021-12-20 0001864032 us-gaap:IPOMember 2022-03-31 0001864032 us-gaap:OverAllotmentOptionMember 2022-03-31 0001864032 us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:PrivatePlacementMember 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember 2021-12-18 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:IPOMember 2021-11-19 2021-11-20 0001864032 us-gaap:IPOMember 2021-12-19 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember 2021-12-19 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-20 0001864032 us-gaap:PrivatePlacementMember 2021-12-19 2021-12-20 0001864032 adrt:SponsorMember 2021-02-23 2021-03-31 0001864032 2021-02-23 0001864032 adrt:SponsorMember us-gaap:PrivatePlacementMember 2022-01-01 2022-03-31 0001864032 adrt:SponsorMember us-gaap:PrivatePlacementMember 2022-03-31 0001864032 us-gaap:PrivatePlacementMember 2022-03-31 0001864032 adrt:PrivatePlacement1Member 2022-03-31 0001864032 adrt:PrivatePlacement2Member 2022-03-31 0001864032 adrt:SponsorMember 2022-01-01 2022-03-31 0001864032 adrt:FounderSharesMember 2021-02-23 0001864032 adrt:SponsorMember adrt:PrivatePlacement1Member 2022-01-01 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001864032 us-gaap:FairValueInputsLevel1Member 2022-03-31 0001864032 us-gaap:FairValueInputsLevel2Member 2022-03-31 0001864032 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001864032 us-gaap:MoneyMarketFundsMember 2021-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001864032 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001864032 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001864032 us-gaap:FairValueInputsLevel3Member 2021-12-31 iso4217:USD shares iso4217:USD shares pure 0001864032 false 2022 Q1 --12-31 116725000 P12M P15M P18M 0 2875000 2875000 P12M P15M P18M 10-Q true 2022-03-31 false 001-41171 AULT DISRUPTIVE TECHNOLOGIES CORPORATION DE 86-2279256 11411 Southern Highlands Pkwy Suite 240 Las Vegas NV 89141 (949) 444-5464 Common Stock, $0.001 par value ADRT NYSEAMER Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 ADRTW NYSEAMER Yes Yes Non-accelerated Filer true true false true 2875000 1109623 1849679 419817 395000 1529440 2244679 293582 375000 116736920 116725166 118559942 119344845 80659 173390 356018 759990 436677 933380 3450000 3450000 3886677 4383380 11500000 11500000 116725000 116725000 0.001 0.001 1000000 1000000 0 0 0 0 0.001 0.001 100000000 100000000 2875000 2875000 2875000 2875000 2875 2875 -2054610 -1766410 -2051735 -1763535 118559942 119344845 296891 958 -296891 -958 3063 11754 8691 -288200 -958 11500000 -0.02 2875000 2500000 -0.02 -0.00 2875000 2875 -1766410 -1763535 -288200 -288200 2875000 2875 -2054610 -2051735 2875000 2875 22125 25000 -958 -958 2875000 2875 22125 -958 24052 -288200 -958 11754 -56601 -346067 958 -589420 150636 -150636 -740056 1849679 1109623 54033 25000 <p id="xdx_80E_ecustom--OrganizationAndBusinessOperations_zTevonO9WjD4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1 — <span id="xdx_829_zYXbnwRVtGE6">Organization and Business Operations</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Organization and General</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ault Disruptive Technologies Corporation (the “Company”) is a blank check company organized on February 22, 2021, under the laws of the State of Delaware. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies with innovative and emerging technologies, products or services in the United States.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2022, the Company had not commenced any operations. All activity for the period from February 22, 2021 (inception) through March 31, 2022, relates to the Company’s formation, the public offering described below and the search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering (the “IPO” or “Public Offering”). The Company has selected December 31 as its fiscal year end.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company’s Sponsor is Ault Disruptive Technologies Company, LLC (the “Sponsor”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Financing</b> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The registration statement for the Company’s IPO was declared effective on December 15, 2021 (the “Effective Date”). On December 20, 2021, the Company consummated its IPO of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20211213__20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zjo63cCNc7Th" title="Stock Issued During Period, Shares, New Issues">10,000,000</span> units at $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20211215__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zOsmCczhtKnh" title="Sale of Stock, Price Per Share">10.00</span> per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one share of common stock, par value of $0.001 per share (the “Common Stock”), and three-fourths of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share. On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Simultaneously with the consummation of the IPO, the Company consummated the private placement of <span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesNewIssues2_pid_uShares_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zXquhuoEmrYa" title="Stock Issued During Period, Shares, New Issues">6,500,000</span> <span id="xdx_903_ecustom--SaleOfStockDescriptionOfTransaction1_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5OO9IM4CgHi" title="Description of stock issuance">warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor</span>, at a price of $1.00 per Private Placement Warrant in a private placement. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_pid_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdQGKHC2Ykv2">7,100,000</span>. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Transaction costs related to the IPO amounted to $<span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20220331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zs8DdedUqe3e" title="Transaction cost">6,297,333</span> consisting of $2,513,333 of underwriting commissions, $3,000,000 of deferred underwriting commissions, and $<span id="xdx_90E_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_c20220331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zjYKahk84RR2" title="Offering cost">784,000</span> of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $<span id="xdx_902_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z66EkaMjNjM">7,122,333</span> consisting of $2,888,333 of underwriting commissions, $3,450,000 of deferred underwriting commissions, and $<span id="xdx_902_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_c20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zh38P3PHGTA7">784,000</span> of other offering costs. In addition, $<span id="xdx_905_ecustom--CashHeld_iI_c20220331_zy3xqIlAbpEc" title="cash held from out side">1,109,623</span> of cash was held outside of the Trust Account (as defined below) as of March 31, 2022 and is available for working capital purposes.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Initial Business Combination</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Trust Account</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Following the closing of the IPO on December 20, 2021, $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDlhhtbepQQh" title="Issuance of common stock to Sponsors (in shares)">116,725,000</span> from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zYSeFum7pLti" title="Sale of stock, price per share">10.15</span> per Unit for the <span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesNewIssues3_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zlhCku1gDFq1" title="Stock issued during period new issues">11,500,000</span> Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFTPJyOjY4N3" title="Issuance of common stock to Sponsors (in shares)">116,725,000</span> was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The trust account is intended as a holding place for funds pending the earliest to occur of: (i) the consummation of the Company’s initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation (A) to modify the substance or timing of its obligation to allow redemptions in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto or to redeem 100% of the Company’s public shares if the Company does not consummate its initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering, the Company’s return of the funds held in the trust account to its public stockholders as part of its redemption of the public shares. If the Company does not invest the proceeds as discussed above, the Company may be deemed to be subject to the Investment Company Act. If the Company is deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which the Company has not allotted funds and may hinder its ability to consummate an initial Business Combination or may result in its liquidation. If the Company is unable to consummate its initial Business Combination, the Company’s public stockholders may receive only approximately $10.15 per public share, or $10.25 or $10.35 per public share, as applicable, on the liquidation of the Company’s trust account and its warrants will expire worthlessly.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will provide holders (the “Public Shareholders”) of its Common Stock sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely at its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Common Stock upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is currently anticipated to be $10.15 per public share.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Common Stock subject to redemption was recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company’s amended and restated articles of incorporation provides that the Company will have only 12 months following the effectiveness of the Public Offering (or up to 18 months following the effectiveness of the Public Offering if the Company extends the period of time to consummate a Business Combination, subject to the Sponsor depositing additional funds in the Trust Account) (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $50,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Sponsor and each member of its management team have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (defined in Note 5), Private Placement Warrants and Public Shares held by them (ii) to waive their redemption rights with respect to their Founder Shares, Private Placement Warrants and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) that would modify the substance or timing of the Company’s obligation to provide holders of shares of Common Stock the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within Combination Period or (B) with respect to any other provision relating to the rights of holders of shares of Common Stock or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Warrants they hold if the Company fails to consummate an initial Business Combination within Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Private Placement Warrants if the Company fails to consummate a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to consummate a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not consummate a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.15, or $10.25 or $10.35 per Public Share, as applicable). </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.15 per Public Share, or $10.25 or $10.35 per Public Share, as applicable, and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Liquidity and Going Concern</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2022, the Company had approximately $<span id="xdx_90F_eus-gaap--Cash_iI_dm_c20220331_zotcTHdj9pn6" title="Cash">1.1 million</span> in its operating bank account and working capital of approximately $<span id="xdx_90A_ecustom--WorkingCapitalAmount_iI_dm_c20220331_zLtcYUvpbJfk" title="Working capital">1.1 million</span>.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In addition, if the Company is unable to consummate the Business Combination within 12 months following the effectiveness of the Initial Public Offering, which is December 15, 2022, the Company may, but is not obligated to, extend the period of time to complete the Business Combination up to two times by an additional three months each time (for a total of up to 18 months to consummate an initial business combination). If the period of time is not extended, the Company will be required to cease all operations except for the purpose of winding up. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date that the financial statement were issued. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Risks and Uncertainties</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company has a limited operating history and has not yet generated revenue from intended operations. The Company’s business and operations are sensitive to general business and economic conditions in the U.S. along with local, state, and federal government policy decisions. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including but not limited to, credit risk, and changes to regulations governing the Company’s industry. Adverse developments in this general business and economic conditions could have a material adverse effect on the Company’s financial condition and the results of its operations. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or searching for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. </p> 10000000 10.00 6500000 warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor 7100000 6297333 784000 7122333 784000 1109623 116725000 10.15 11500000 116725000 1100000 1100000 <p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zGdoTi6XIjo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2 — <span id="xdx_82D_z0Lq2NoaoDsb">Summary of Significant Accounting Policies</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z24gP16LgER6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86B_zPJ3QHdA7aV6">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 15, 2022.</p> <p id="xdx_850_zjSuczi8hNtk" style="margin: 0"> </p> <p id="xdx_849_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zFU0whf0oZ1b" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86E_zQJt8ZV7yEZ9">Emerging Growth Company Status</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company intends to take advantage of the benefits of this extended transition period.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the effectiveness of the Initial Public Offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Additionally, the Company is a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates equals or exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30th.  </p> <p id="xdx_85A_zzmoCHY79TEb" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_840_eus-gaap--UseOfEstimates_z6fmKI8jBpJ7" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_865_zqgYPy42yWD4">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The preparation of the financial statements are in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> <p id="xdx_85A_zTTGYKgfG6Wb" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_844_ecustom--AccountingPolicyOnRedeemableSharesPolicyTextBlock_zxaPeR3HIor" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86B_zZeB8ujQDuQ2">Accounting Policy on Redeemable Shares</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will account for its Common Stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, shares of common stock will be classified as shareholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Accordingly, <span id="xdx_904_ecustom--CommonStockSharesAuthorizedRedemption_iI_pid_uShares_c20220331_zfhIk8aXhml2">11,500,000</span> shares of Common Stock are subject to possible redemption, which are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid-in capital and accumulated deficit. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_896_ecustom--RedeemableSharesTableTextBlock_zRAkb4X2gnh6" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white"><span id="xdx_8BB_zSRelinQdg39">As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:</span></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20220101__20220331_z1CyMbCjDXA3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ProceedsFromIssuanceOfCommonStock1_zCgWbWhcS6ek" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 82%; text-align: left">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">115,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ProceedsAllocatedToPrivatePlacementWarrants_zTr7CXkHsqcd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; white-space: nowrap; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,312,500</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--IssuanceCostsAllocatedToCommonStock_zvtiwVV4FoRe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; white-space: nowrap; text-align: left">Issuance costs allocated to common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,866,913</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AccretionOfCarryingValueToRedemptionValue_zyl3XGH9OZxl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; white-space: nowrap; padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,904,413</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--CommonStockSubjectToPossibleRedemption1_dxL_zDorg4izu9Bc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left; padding-bottom: 2.5pt">Common stock subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">116,725,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zAKHXWOCSwv8" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_851_zD9i5xdo6Is7" style="font: 10pt Times New Roman; margin: 0pt 0"><b/></p> <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z5MfdbITMnU9" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86C_zz2MQPxYA2qb">Cash and Cash Equivalents</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,109,623 in cash and no cash equivalents as of March 31, 2022.</p> <p id="xdx_85B_zOjxrUGRLARa" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_841_eus-gaap--MarketableSecuritiesPolicy_zlGARZalnycj" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_866_z8bimkz7DVKk">Marketable Securities Held in Trust Account</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As of March 31, 2022, the Company held $116,736,920, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2022, the Company did not withdraw any interest income from the Trust Account to pay its tax obligations.</p> <p id="xdx_854_zGPzebHkC6Kj" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zm4HVFUmvAl1" style="font: 10pt Times New Roman; margin: 0pt 0"><b><span id="xdx_867_zL4Ok0ikKC5c">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.</p> <p id="xdx_85D_z83Mim4fzCzc" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_848_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z3G4okSxRwTc" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zWBvA7LonI71">Fair Value of Financial Instruments</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. </p> <p id="xdx_851_zJfXs6VQkmt8" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_842_ecustom--OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock_zyd0kuIn69H8" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zJzcHt2wR5Ja">Offering Costs associated with the Initial Public Offering</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Offering costs consist of underwriting, legal, accounting, and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to shareholders’ deficit. Deferred underwriting commissions are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</p> <p id="xdx_85B_zdH3Ebzjj9Wd" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84D_ecustom--WarrantInstrumentsPolicyTextBlock_zy8Y9mmpauO1" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zcVbm3F7EXWa">Warrant Instruments</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will account for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. </p> <p id="xdx_853_z31Qb6Iz8HS3" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z2Dpey9XHdya" style="font: 10pt Times New Roman; margin: 0pt 0; background-color: white"><b><span id="xdx_868_z0X7OSBomNai">Net Loss per Share of Common Stock</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company complies with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2022, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted income per share is the same as basic income per share for the period presented.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_zixzxZmJneic" style="font: 10pt Times New Roman; margin: 0pt 0"><span style="background-color: white"><span id="xdx_8B2_z0I15Xn5HnHl">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>For the Three Months Ended </b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>March 31, 2022</b></p></td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock <br/> Subject to <br/> Redemption</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non-<br/> Redeemable <br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net loss per common stock</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; white-space: nowrap; width: 58%; text-align: left">Allocation of net loss, as adjusted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholdersBasicRedeemable_c20220101__20220331_z1FwRkvBYZQ7" style="width: 18%; text-align: right" title="Allocation of net loss, as adjusted redeemable">(230,560</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20220101__20220331_zewKEQpjuBSk" style="width: 18%; text-align: right" title="Allocation of net loss, as adjusted non redeemable">(57,640</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; white-space: nowrap; padding-bottom: 1pt">Basic and diluted weighted average shares outstanding</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--WeightedAverageNumberOfShareOutstandingBasicAndDilutedRedemption_c20220101__20220331_zPOdqHjvadQb" style="border-bottom: Black 1pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding redeemable">11,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--WeightedAverageNumberOfShareOutstandingBasicAndDilutedOne_c20220101__20220331_z6LI9gbHjqKi" style="border-bottom: Black 1pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding non redeemable">2,875,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left">Basic and diluted net loss per common stock</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EarningsPerShareBasicAndDilutedRedemption_pid_uUSDPShares_c20220101__20220331_zYNjg7ypdC9a" style="text-align: right" title="Basic and diluted net loss per common stock redemable">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--EarningsPerShareBasicAndDilutedOne_pid_uUSDPShares_c20220101__20220331_z4izvWCMZuY4" style="text-align: right" title="Basic and diluted net loss per common stock non redemable">(0.02</td><td style="text-align: left">)</td></tr> </table> <p id="xdx_8AA_zmhChIMAb6Uh" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_85A_zTNxgFoHn3Pc" style="font: 10pt Times New Roman; margin: 0pt 0"><b/></p> <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zZD1oG23sj35" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zqk7mtdGTOr7">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company assesses its income tax positions and records tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances, and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, the Company’s policy is to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company expects to file a U.S. federal tax return. The Company was formed in 2021 and has not been required to file any tax returns. All tax periods since inception remain open to examination by the taxing jurisdictions to which the Company is subject. </p> <p id="xdx_85E_zNPykIfzWZYd" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKRcXgzy1bQ7" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86F_zieJOrTziCN3">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2022 and the adoption did not have an impact on its financial position, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.</p> <p id="xdx_855_z95qg43BEqW6" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z24gP16LgER6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86B_zPJ3QHdA7aV6">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 15, 2022.</p> <p id="xdx_849_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zFU0whf0oZ1b" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86E_zQJt8ZV7yEZ9">Emerging Growth Company Status</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company intends to take advantage of the benefits of this extended transition period.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the effectiveness of the Initial Public Offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Additionally, the Company is a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates equals or exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30th.  </p> <p id="xdx_840_eus-gaap--UseOfEstimates_z6fmKI8jBpJ7" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_865_zqgYPy42yWD4">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The preparation of the financial statements are in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> <p id="xdx_844_ecustom--AccountingPolicyOnRedeemableSharesPolicyTextBlock_zxaPeR3HIor" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86B_zZeB8ujQDuQ2">Accounting Policy on Redeemable Shares</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will account for its Common Stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, shares of common stock will be classified as shareholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Accordingly, <span id="xdx_904_ecustom--CommonStockSharesAuthorizedRedemption_iI_pid_uShares_c20220331_zfhIk8aXhml2">11,500,000</span> shares of Common Stock are subject to possible redemption, which are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid-in capital and accumulated deficit. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_896_ecustom--RedeemableSharesTableTextBlock_zRAkb4X2gnh6" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white"><span id="xdx_8BB_zSRelinQdg39">As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:</span></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20220101__20220331_z1CyMbCjDXA3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ProceedsFromIssuanceOfCommonStock1_zCgWbWhcS6ek" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 82%; text-align: left">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">115,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ProceedsAllocatedToPrivatePlacementWarrants_zTr7CXkHsqcd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; white-space: nowrap; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,312,500</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--IssuanceCostsAllocatedToCommonStock_zvtiwVV4FoRe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; white-space: nowrap; text-align: left">Issuance costs allocated to common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,866,913</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AccretionOfCarryingValueToRedemptionValue_zyl3XGH9OZxl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; white-space: nowrap; padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,904,413</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--CommonStockSubjectToPossibleRedemption1_dxL_zDorg4izu9Bc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left; padding-bottom: 2.5pt">Common stock subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">116,725,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zAKHXWOCSwv8" style="margin-top: 0; margin-bottom: 0"> </p> 11500000 <p id="xdx_896_ecustom--RedeemableSharesTableTextBlock_zRAkb4X2gnh6" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white"><span id="xdx_8BB_zSRelinQdg39">As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:</span></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20220101__20220331_z1CyMbCjDXA3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ProceedsFromIssuanceOfCommonStock1_zCgWbWhcS6ek" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 82%; text-align: left">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">115,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap">Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ProceedsAllocatedToPrivatePlacementWarrants_zTr7CXkHsqcd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; white-space: nowrap; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,312,500</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--IssuanceCostsAllocatedToCommonStock_zvtiwVV4FoRe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; white-space: nowrap; text-align: left">Issuance costs allocated to common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,866,913</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap">Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AccretionOfCarryingValueToRedemptionValue_zyl3XGH9OZxl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; white-space: nowrap; padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,904,413</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--CommonStockSubjectToPossibleRedemption1_dxL_zDorg4izu9Bc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left; padding-bottom: 2.5pt">Common stock subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">116,725,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 115000000 -4312500 -6866913 12904413 <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z5MfdbITMnU9" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86C_zz2MQPxYA2qb">Cash and Cash Equivalents</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,109,623 in cash and no cash equivalents as of March 31, 2022.</p> <p id="xdx_841_eus-gaap--MarketableSecuritiesPolicy_zlGARZalnycj" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_866_z8bimkz7DVKk">Marketable Securities Held in Trust Account</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As of March 31, 2022, the Company held $116,736,920, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2022, the Company did not withdraw any interest income from the Trust Account to pay its tax obligations.</p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zm4HVFUmvAl1" style="font: 10pt Times New Roman; margin: 0pt 0"><b><span id="xdx_867_zL4Ok0ikKC5c">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.</p> <p id="xdx_848_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z3G4okSxRwTc" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zWBvA7LonI71">Fair Value of Financial Instruments</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. </p> <p id="xdx_842_ecustom--OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock_zyd0kuIn69H8" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zJzcHt2wR5Ja">Offering Costs associated with the Initial Public Offering</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Offering costs consist of underwriting, legal, accounting, and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to shareholders’ deficit. Deferred underwriting commissions are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</p> <p id="xdx_84D_ecustom--WarrantInstrumentsPolicyTextBlock_zy8Y9mmpauO1" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zcVbm3F7EXWa">Warrant Instruments</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will account for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. </p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z2Dpey9XHdya" style="font: 10pt Times New Roman; margin: 0pt 0; background-color: white"><b><span id="xdx_868_z0X7OSBomNai">Net Loss per Share of Common Stock</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company complies with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2022, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted income per share is the same as basic income per share for the period presented.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_zixzxZmJneic" style="font: 10pt Times New Roman; margin: 0pt 0"><span style="background-color: white"><span id="xdx_8B2_z0I15Xn5HnHl">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>For the Three Months Ended </b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>March 31, 2022</b></p></td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock <br/> Subject to <br/> Redemption</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non-<br/> Redeemable <br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net loss per common stock</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; white-space: nowrap; width: 58%; text-align: left">Allocation of net loss, as adjusted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholdersBasicRedeemable_c20220101__20220331_z1FwRkvBYZQ7" style="width: 18%; text-align: right" title="Allocation of net loss, as adjusted redeemable">(230,560</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20220101__20220331_zewKEQpjuBSk" style="width: 18%; text-align: right" title="Allocation of net loss, as adjusted non redeemable">(57,640</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; white-space: nowrap; padding-bottom: 1pt">Basic and diluted weighted average shares outstanding</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--WeightedAverageNumberOfShareOutstandingBasicAndDilutedRedemption_c20220101__20220331_zPOdqHjvadQb" style="border-bottom: Black 1pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding redeemable">11,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--WeightedAverageNumberOfShareOutstandingBasicAndDilutedOne_c20220101__20220331_z6LI9gbHjqKi" style="border-bottom: Black 1pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding non redeemable">2,875,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left">Basic and diluted net loss per common stock</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EarningsPerShareBasicAndDilutedRedemption_pid_uUSDPShares_c20220101__20220331_zYNjg7ypdC9a" style="text-align: right" title="Basic and diluted net loss per common stock redemable">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--EarningsPerShareBasicAndDilutedOne_pid_uUSDPShares_c20220101__20220331_z4izvWCMZuY4" style="text-align: right" title="Basic and diluted net loss per common stock non redemable">(0.02</td><td style="text-align: left">)</td></tr> </table> <p id="xdx_8AA_zmhChIMAb6Uh" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_zixzxZmJneic" style="font: 10pt Times New Roman; margin: 0pt 0"><span style="background-color: white"><span id="xdx_8B2_z0I15Xn5HnHl">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>For the Three Months Ended </b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>March 31, 2022</b></p></td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock <br/> Subject to <br/> Redemption</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non-<br/> Redeemable <br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net loss per common stock</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; white-space: nowrap; width: 58%; text-align: left">Allocation of net loss, as adjusted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholdersBasicRedeemable_c20220101__20220331_z1FwRkvBYZQ7" style="width: 18%; text-align: right" title="Allocation of net loss, as adjusted redeemable">(230,560</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20220101__20220331_zewKEQpjuBSk" style="width: 18%; text-align: right" title="Allocation of net loss, as adjusted non redeemable">(57,640</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 18pt; white-space: nowrap; padding-bottom: 1pt">Basic and diluted weighted average shares outstanding</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--WeightedAverageNumberOfShareOutstandingBasicAndDilutedRedemption_c20220101__20220331_zPOdqHjvadQb" style="border-bottom: Black 1pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding redeemable">11,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--WeightedAverageNumberOfShareOutstandingBasicAndDilutedOne_c20220101__20220331_z6LI9gbHjqKi" style="border-bottom: Black 1pt solid; text-align: right" title="Basic and diluted weighted average shares outstanding non redeemable">2,875,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; text-align: left">Basic and diluted net loss per common stock</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EarningsPerShareBasicAndDilutedRedemption_pid_uUSDPShares_c20220101__20220331_zYNjg7ypdC9a" style="text-align: right" title="Basic and diluted net loss per common stock redemable">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--EarningsPerShareBasicAndDilutedOne_pid_uUSDPShares_c20220101__20220331_z4izvWCMZuY4" style="text-align: right" title="Basic and diluted net loss per common stock non redemable">(0.02</td><td style="text-align: left">)</td></tr> </table> -230560 -57640 11500000 2875000 -0.02 -0.02 <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zZD1oG23sj35" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zqk7mtdGTOr7">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company assesses its income tax positions and records tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances, and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, the Company’s policy is to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company expects to file a U.S. federal tax return. The Company was formed in 2021 and has not been required to file any tax returns. All tax periods since inception remain open to examination by the taxing jurisdictions to which the Company is subject. </p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKRcXgzy1bQ7" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86F_zieJOrTziCN3">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2022 and the adoption did not have an impact on its financial position, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.</p> <p id="xdx_800_ecustom--InitialPublicOffering_zExu9FAiGte2" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 3 — <span id="xdx_82E_zFcU1LIPH6Kb">Initial Public Offering</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On December 20, 2021, the Company consummated its IPO of <span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesNewIssuesOne_pid_uShares_c20211218__20211220__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zBcwPlx8nD22" title="Stock Issued During Period, Shares, New Issues">10,000,000</span> Units at a purchase price of $<span id="xdx_901_ecustom--SharesPurchasePricePerShares_pid_c20211119__20211120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zBxNcObIguD7" title="Shares purchase price (in dollars per share)">10.00 </span>per Unit. <span id="xdx_908_eus-gaap--SaleOfStockDescriptionOfTransaction_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zU0P9WpAAzne" title="Sale of stock, description of transaction">Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant</span>. Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment (see Note 7). On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zK15m30SMidk" title="Issuance of common stock to sponsors (in shares)">11,500,000</span> and generated gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z1jciOx5voge" title="Proceeds from issuance of private placement warrants">115,000,000</span>. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Following the closing of the IPO on December 20, 2021, $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDEJEwUC7gp7" title="Issuance of common stock to sponsors (in shares)">116,725,000</span> from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the Trust Account. This amount was comprised of $<span id="xdx_902_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights11_iI_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhXA5tvduHBa" title="Share price per unit">10.15</span> per Unit for the <span id="xdx_901_ecustom--StockIssuedDuringPeriodSharesNewIssues3_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zqO3elZIBMU3" title="Stock issued during period new issues">11,500,000</span> Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z7BNwb4QP9ac" title="Issuance of common stock to sponsors (in shares)">116,725,000</span> ($<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zHN7975IKX92" title="Share price per unit">10.15</span> per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. </p> 10000000 10.00 Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant 11500000 115000000 116725000 10.15 11500000 116725000 10.15 <p id="xdx_809_ecustom--PrivatePlacement_zdWkV8HTeiZg" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 4 — <span id="xdx_828_zDJyihlMoCWj">Private Placement</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zy4qFAR9FCQ1" title="Issuance of common stock to sponsors (in shares)">6,500,000</span> Private Placement <span id="xdx_90F_eus-gaap--SaleOfStockDescriptionOfTransaction_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zJUEKPQibVSa" title="Sale of stock, description of transaction">Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021), each exercisable to purchase one</span> share of Common Stock at $<span id="xdx_90E_ecustom--SaleOfStockPricePerShare3_iI_pid_uUSDPShares_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zohd9feVRPuc" title="Exercise price per share">11.50</span> per share, at a price of $<span id="xdx_907_ecustom--SaleOfStockPricePerShare1_iI_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhtoZUPUZF66">1.00</span> per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220331_z0NyD0WNHYL1" title="Proceeds from option exercise">7,100,000</span>. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Private Placement Warrants are not transferable, assignable or salable (and the shares of Common Stock issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination).</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the Public Offering. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants requires a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.</p> 6500000 Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021), each exercisable to purchase one 11.50 1.00 7100000 <p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zawqDr25dks1" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 5 — <span id="xdx_82F_zWuKLd7SxyMk">Related Party Transactions</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Founder Shares</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On February 23, 2021, the Company issued the Sponsor an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20210223__20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zrAMUkgTk4k9" title="Shares issued for services">2,875,000</span> shares of the Company’s common stock, par value $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20210223_zqV2P9BwlF0j">0.001</span> per share (the “Founder Shares”) for an aggregate purchase price of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210223__20210331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z1ixAuTFWVS7" title="Aggregate purchase price">25,000</span>. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $<span id="xdx_903_ecustom--CommonStockParOrStatedValuePerShare1_iI_pid_uUSDPShares_c20210223_zwnCgw8X7xJa" title="Common stock par or stated value per share">12.00</span> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Private Placement Warrants</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 40pt">The Sponsor purchased an aggregate of <span id="xdx_903_ecustom--UnderwritingFees_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zeUGwDhoetLd" title="Underwriting fees">7,100,000</span> Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ziA6FQjrXyMi" title="Exercise price (in dollars per share)">1.00 </span>per warrant, for an aggregate purchase price of $<span id="xdx_907_ecustom--UnderwritingFees_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zfJHmNnCYuc8" title="Underwriting fees">7,100,000</span>. Each Private Placement Warrant is identical to the Public Warrants, except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtMxL_c20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zNsEJOzJayPa" title="Warrant terms::XDX::P12M"><span style="-sec-ix-hidden: xdx2ixbrl0432">12</span></span> months (or up to <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtMxL_c20220331__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacement1Member_zsNBnmCcb8zc" title="Warrant terms::XDX::P15M"><span style="-sec-ix-hidden: xdx2ixbrl0434">15</span></span> months or <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtMxL_c20220331__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacement2Member_zEA7AF67JMLf" title="Warrant terms::XDX::P18M"><span style="-sec-ix-hidden: xdx2ixbrl0436">18</span></span> months, as applicable) following the effectiveness of the Initial Public Offering.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Related Party Loans</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). The terms of the Working Capital Loans have not been determined nor have any written agreements been executed with respect thereto. The Working Capital Loan totaling $<span id="xdx_906_ecustom--WorkingCapitalLoan_iI_c20220331_zmXUvj2eTMnd" title="Working capital loan">366,000</span> was repaid out of the offering proceeds not held in the Trust Account. As of March 31, 2022 and December 31, 2021, the Working Capital Loans were repaid in full. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Administrative Services Agreement</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company’s Sponsor through the earlier of the Company’s consummation of a Business Combination and its liquidation, makes available to the Company certain general and administrative services, including office space, utilities, and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $<span id="xdx_909_eus-gaap--SponsorFees_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zaZpygVF0Gza" title="Sponsor fees">10,000</span> per month for these services. The Company incurred $<span id="xdx_906_eus-gaap--OperatingCostsAndExpenses_c20220101__20220331_zgQDCJIXgqF9" title="Operating cost">30,000</span> in operating cost associated with the administrative service fees for the three months ended March 31, 2022.</p> 2875000 0.001 25000 12.00 7100000 1.00 7100000 366000 10000 30000 <p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zS8GLlGgtTr7" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 6 — <span id="xdx_824_zyXNJZDWdlM2">Commitments and Contingencies</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In the course of normal operations, the Company may be involved in various claims and litigation that management intends to defend. The range of loss, if any, from potential claims cannot be reasonably estimated. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Registration and Shareholder Rights</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The holders of the Founder Shares, Public Warrants, and Private Placement Warrants that may be issued upon conversion of Working Capital Loans (and any shares of Common Stock issuable upon the exercise of the Private Placement Warrants, including those issued upon conversion of the working capital loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that no sales of these securities will be effected until after the expiration of the applicable lock-up period, as described herein. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Underwriting Agreement</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 1,500,000 Units to cover over-allotments if any. On December 20, 2021, the underwriters fully exercised the over-allotment option. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The underwriters were paid at the closing of the IPO an underwriting commission of $0.25 per Unit sold in the IPO or $2,513,333. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $375,000 for an aggregate of $2,888,333 in underwriting commissions related to the IPO and over-allotment.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In addition, $3,000,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $450,000 for an aggregate of $3,450,000 in deferred underwriting commissions related to the IPO and over-allotment. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </p> <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zTgndpwRKS6a" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 7 — <span id="xdx_822_zAMT4tgvFpQ2">Stockholders’ Equity</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Preferred Stock</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company is authorized to issue <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_dxL_uShares_c20220331_zt0epNqbDsUa" title="Preferred stock, shares issued::XDX::0"><span style="-sec-ix-hidden: xdx2ixbrl0448">1,000,000</span></span> preferred shares with a par value of $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20220331_z2HRblAQttO6">0.001</span> and with such designations, voting, and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2022, there were no preferred shares issued or outstanding. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Common Stock</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company is authorized to issue <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pid_dxL_uShares_c20220331_zfLyRvuAHnM3" title="Common stock, shares, issued::XDX::2875000"><span style="-sec-ix-hidden: xdx2ixbrl0451">100,000,000 </span></span>shares of Common Stock with a par value of $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20220331_z3VR5452GOJf">0.001</span> per share. As of March 31, 2022, there were <span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20220331_zeIuxLCHH8g1" title="Common stock, shares, outstanding">2,875,000</span> shares of Common Stock outstanding, excluding 11,500,000 shares of Common Stock subject to possible redemption issued.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b><i>Founder Shares</i></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 23, 2021, the Sponsor purchased the <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_dxL_uShares_c20210223__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zSedyAszgAKi" title="Common stock, shares, issued"><span style="-sec-ix-hidden: xdx2ixbrl0456">2,875,000</span></span> Founder Shares for an aggregate price of $<span id="xdx_90C_eus-gaap--CommonStockValue_iI_c20210223_zdqGOwVO9Cqk" title="Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding">25,000</span>.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of the Founder Shares will agree, subject to limited exceptions, not to transfer, assign or sell their Founder Shares, for a period ending on the date that is the earlier of (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b><i>Public Warrants and Private Placement Warrants</i></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants were issued upon separation of the Units and only whole Public Warrants trade. The Public Warrants will become exercisable on the later of (a) one year after the date that the registration statement for the offering is declared effective by the SEC and (b) the consummation of a Business Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExpenseOrRevenueRecognized_c20220101__20220331_zL0YBr4etX0l" title="Class of warrant or right, expense or revenue recognized">The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price</span>.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is not effective by the 60th business day following the consummation of the Company’s initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 22.5pt"/><td style="width: 18pt">•</td><td style="text-align: justify">in whole and not in part;</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 22.5pt"/><td style="width: 18pt">•</td><td style="text-align: justify">at a price of $0.01 per warrant;</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 22.5pt"/><td style="width: 18pt">•</td><td style="text-align: justify">upon not less than 30 days prior written notice of redemption given after the warrants become exercisable (the “30-day redemption period”) to each warrant holder; and</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 22.5pt"/><td style="width: 18pt">•</td><td style="text-align: justify">if, and only if, the reported last sale price of the Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three days before the Company sends the notice of redemption to the warrant holders.</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Common Stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of Common Stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares of Common Stock under the blue sky laws of the state of residence in those states in which the warrants were offered by the Company in the Public Offering.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 24pt">If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the Company’s management will consider, among other factors, its cash position, the number of outstanding warrants and the dilutive effect on the Company’s stockholders of issuing the maximum number of shares of Common Stock issuable upon the exercise of the Company’s warrants. In such an event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 24pt">The Sponsor purchased an aggregate of <span id="xdx_904_ecustom--UnderwritingFees_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ztKTpippzum" title="Underwriting fees">7,100,000</span> Private Placement Warrants, which includes the <span id="xdx_90C_ecustom--UnderwritingFees_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacement1Member_zmetw2lBaL9a" title="Underwriting fees">600,000</span> Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zO7Q83GcUB3i" title="Exercise price (in dollars per share)">1.00</span> per warrant, for an aggregate purchase price of $<span id="xdx_90F_ecustom--UnderwritingFees_c20220101__20220331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zNRIHTAjlBbh" title="Underwriting fees">7,100,000</span>. Each Private Placement Warrant is identical to the Public Warrants except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtMxL_c20220331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zH7tBArmQMr4" title="Warrant terms::XDX::P12M"><span style="-sec-ix-hidden: xdx2ixbrl0471">12</span></span> months (or up to <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtMxL_c20220331__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacement1Member_zpfFEdUjR17c" title="Warrant terms::XDX::P15M"><span style="-sec-ix-hidden: xdx2ixbrl0473">15</span></span> months or <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtMxL_c20220331__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacement2Member_zuvcKdJ5ousj" title="Warrant terms::XDX::P18M"><span style="-sec-ix-hidden: xdx2ixbrl0475">18</span></span> months, as applicable) following the effectiveness of the Public Offering. The Company’s initial stockholders have agreed to waive their redemption rights with respect to any Founder Shares or Private Placement Warrants (i) in connection with the consummation of a Business Combination, (ii) in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of its obligation to allow redemption in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto, to redeem 100% of the Company’s Public Shares if the Company does not consummate its initial Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) if the Company fails to consummate a Business Combination within 12 months (or up to 15 months or 18 months, as applicable) following the effectiveness of the Public Offering or if the Company liquidates prior to the expiration of the 12-month period (or 15-month period or 18-month period, as applicable). However, the Company’s initial stockholders will be entitled to redemption rights with respect to any Public Shares held by them if the Company fails to consummate a Business Combination or liquidate within the 12-month period (or 15-month period or 18-month period, as applicable).</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-indent: 0.5in">All warrants meet the requirements for equity classification and the Company accounts for the warrants as equity instruments in accordance with ASC 815, "Derivatives and Hedging", effective with the Public Offering.</p> 0.001 0.001 2875000 25000 The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price 7100000 600000 1.00 7100000 <p id="xdx_805_eus-gaap--FairValueDisclosuresTextBlock_zVCse2A4aaxl" style="font: 10pt Times New Roman; margin: 0pt 0"><span style="background-color: white"><b>Note 8 - <span id="xdx_82A_zVWwYOgmAsB4">Fair Value Measurements</span></b></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 31.5pt"/><td style="width: 13.5pt">●</td><td style="text-align: justify">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 31.5pt"/><td style="width: 13.5pt">●</td><td style="text-align: justify">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 31.5pt"/><td style="width: 13.5pt">●</td><td style="text-align: justify">Level 3, is defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z3uc82eZpKR7" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white"><span id="xdx_8B3_ztEzBa5d73ha">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">March 31,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Quoted</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Prices In</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Active</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Markets</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Observable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Unobservable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Description</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Assets:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 40%; text-align: left; padding-bottom: 1pt">U.S. Money Market Funds held in Trust Account</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zbplbH9CJiT2" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">116,736,920</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbOYPTVfK0qe" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">116,736,920</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zu9i2c17jxgb" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0485">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zP2Qzu5RRDpl" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0486">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20220331_zaWgQTq5NrVb" style="border-bottom: Black 2.5pt double; text-align: right">116,736,920</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJwDBDtp2c8b" style="border-bottom: Black 2.5pt double; text-align: right">116,736,920</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zUDr3t4eLczj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZvlX9Seerf" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Quoted</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Prices In</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Active</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Markets</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Observable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Unobservable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Description</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Assets:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 40%; text-align: left; padding-bottom: 1pt">U.S. Money Market Funds held in Trust Account</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zuftUSR7BoW3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">116,725,166</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zSGn2wZCXbP8" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">116,725,166</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7Q3BYgTf1l1" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zirSLFvwyhu1" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20211231_zVx7yQnJ0Oc" style="border-bottom: Black 2.5pt double; text-align: right">116,725,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zD0j9ay5PoQk" style="border-bottom: Black 2.5pt double; text-align: right">116,725,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8sYb1gaLmUg" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0497">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrCP4ghaKtW2" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0498">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zsc164dV4L62" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">There were no transfers between Levels 1, 2 or 3 from inception to December 31, 2021</span> and during the three months ended March 31, 2022.</p> <p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z3uc82eZpKR7" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white"><span id="xdx_8B3_ztEzBa5d73ha">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">March 31,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Quoted</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Prices In</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Active</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Markets</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Observable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Unobservable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Description</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Assets:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 40%; text-align: left; padding-bottom: 1pt">U.S. Money Market Funds held in Trust Account</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zbplbH9CJiT2" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">116,736,920</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbOYPTVfK0qe" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">116,736,920</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zu9i2c17jxgb" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0485">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zP2Qzu5RRDpl" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0486">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20220331_zaWgQTq5NrVb" style="border-bottom: Black 2.5pt double; text-align: right">116,736,920</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJwDBDtp2c8b" style="border-bottom: Black 2.5pt double; text-align: right">116,736,920</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zUDr3t4eLczj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZvlX9Seerf" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Quoted</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Prices In</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Active</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Markets</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Observable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Unobservable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Description</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Assets:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 40%; text-align: left; padding-bottom: 1pt">U.S. Money Market Funds held in Trust Account</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_zuftUSR7BoW3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">116,725,166</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zSGn2wZCXbP8" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">116,725,166</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7Q3BYgTf1l1" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zirSLFvwyhu1" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20211231_zVx7yQnJ0Oc" style="border-bottom: Black 2.5pt double; text-align: right">116,725,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zD0j9ay5PoQk" style="border-bottom: Black 2.5pt double; text-align: right">116,725,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8sYb1gaLmUg" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0497">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrCP4ghaKtW2" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0498">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 116736920 116736920 116736920 116736920 116725166 116725166 116725166 116725166 <p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zHZAshIXDBR4" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 9 — <span id="xdx_82A_zwZhHklj0utg">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statement.</p> EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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�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end XML 39 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 40 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 67 140 1 false 17 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://adrt.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONDENSED BALANCE SHEETS (unaudited) Sheet http://adrt.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS (unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED BALANCE SHEETS (unaudited) (Parenthetical) Sheet http://adrt.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Sheet http://adrt.com/role/UnauditedCondensedStatementsOfOperations UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 00000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS Sheet http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Business Operations Sheet http://adrt.com/role/OrganizationAndBusinessOperations Organization and Business Operations Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://adrt.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Initial Public Offering Sheet http://adrt.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 00000010 - Disclosure - Private Placement Sheet http://adrt.com/role/PrivatePlacement Private Placement Notes 10 false false R11.htm 00000011 - Disclosure - Related Party Transactions Sheet http://adrt.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 00000012 - Disclosure - Commitments and Contingencies Sheet http://adrt.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders??? Equity Sheet http://adrt.com/role/StockholdersEquity Stockholders??? Equity Notes 13 false false R14.htm 00000014 - Disclosure - Fair Value Measurements Sheet http://adrt.com/role/FairValueMeasurements Fair Value Measurements Notes 14 false false R15.htm 00000015 - Disclosure - Subsequent Events Sheet http://adrt.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://adrt.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://adrt.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://adrt.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - Fair Value Measurements (Tables) Sheet http://adrt.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://adrt.com/role/FairValueMeasurements 18 false false R19.htm 00000019 - Disclosure - Organization and Business Operations (Details Narrative) Sheet http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative Organization and Business Operations (Details Narrative) Details http://adrt.com/role/OrganizationAndBusinessOperations 19 false false R20.htm 00000020 - Disclosure - As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table: (Details) Sheet http://adrt.com/role/AsOfMarch312022SharesOfCommonStockReflectedInBalanceSheetAreReconciledInFollowingTableDetails As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table: (Details) Details 20 false false R21.htm 00000021 - Disclosure - The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts): (Details) Sheet http://adrt.com/role/FollowingTableReflectsCalculationOfBasicAndDilutedNetLossPerCommonShareInDollarsExceptPerShareAmountsDetails The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts): (Details) Details 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://adrt.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://adrt.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 00000023 - Disclosure - Initial Public Offering (Details Narrative) Sheet http://adrt.com/role/InitialPublicOfferingDetailsNarrative Initial Public Offering (Details Narrative) Details http://adrt.com/role/InitialPublicOffering 23 false false R24.htm 00000024 - Disclosure - Private Placement (Details Narrative) Sheet http://adrt.com/role/PrivatePlacementDetailsNarrative Private Placement (Details Narrative) Details http://adrt.com/role/PrivatePlacement 24 false false R25.htm 00000025 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://adrt.com/role/RelatedPartyTransactions 25 false false R26.htm 00000026 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://adrt.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://adrt.com/role/StockholdersEquity 26 false false R27.htm 00000027 - Disclosure - The following table presents information about the Company???s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determi (Details) Sheet http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails The following table presents information about the Company???s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determi (Details) Details 27 false false All Reports Book All Reports adtc51022010q.htm adrt-20220331.xsd adrt-20220331_cal.xml adrt-20220331_def.xml adrt-20220331_lab.xml adrt-20220331_pre.xml ex31_1.htm ex31_2.htm ex32_1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 44 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "adtc51022010q.htm": { "axisCustom": 0, "axisStandard": 7, "contextCount": 67, "dts": { "calculationLink": { "local": [ "adrt-20220331_cal.xml" ] }, "definitionLink": { "local": [ "adrt-20220331_def.xml" ] }, "inline": { "local": [ "adtc51022010q.htm" ] }, "labelLink": { "local": [ "adrt-20220331_lab.xml" ] }, "presentationLink": { "local": [ "adrt-20220331_pre.xml" ] }, "schema": { "local": [ "adrt-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 235, "entityCount": 1, "hidden": { "http://adrt.com/20220331": 7, "http://fasb.org/us-gaap/2022": 48, "http://xbrl.sec.gov/dei/2022": 5, "total": 60 }, "keyCustom": 39, "keyStandard": 101, "memberCustom": 6, "memberStandard": 10, "nsprefix": "adrt", "nsuri": "http://adrt.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://adrt.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:PrivatePlacement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Private Placement", "role": "http://adrt.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:PrivatePlacement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Related Party Transactions", "role": "http://adrt.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Commitments and Contingencies", "role": "http://adrt.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Stockholders\u2019 Equity", "role": "http://adrt.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Fair Value Measurements", "role": "http://adrt.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Subsequent Events", "role": "http://adrt.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "adrt:AccountingPolicyOnRedeemableSharesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:RedeemableSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "adrt:AccountingPolicyOnRedeemableSharesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:RedeemableSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Fair Value Measurements (Tables)", "role": "http://adrt.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "p", "adrt:PrivatePlacement", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Organization and Business Operations (Details Narrative)", "role": "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "shortName": "Organization and Business Operations (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "adrt:OrganizationAndBusinessOperations", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "lang": null, "name": "adrt:CashHeld", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONDENSED BALANCE SHEETS (unaudited)", "role": "http://adrt.com/role/CondensedBalanceSheets", "shortName": "CONDENSED BALANCE SHEETS (unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "adrt:RedeemableSharesTableTextBlock", "adrt:AccountingPolicyOnRedeemableSharesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "adrt:ProceedsFromIssuanceOfCommonStock1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table: (Details)", "role": "http://adrt.com/role/AsOfMarch312022SharesOfCommonStockReflectedInBalanceSheetAreReconciledInFollowingTableDetails", "shortName": "As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "adrt:RedeemableSharesTableTextBlock", "adrt:AccountingPolicyOnRedeemableSharesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "adrt:ProceedsFromIssuanceOfCommonStock1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "adrt:NetIncomeLossAvailableToCommonStockholdersBasicRedeemable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts): (Details)", "role": "http://adrt.com/role/FollowingTableReflectsCalculationOfBasicAndDilutedNetLossPerCommonShareInDollarsExceptPerShareAmountsDetails", "shortName": "The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts): (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "adrt:NetIncomeLossAvailableToCommonStockholdersBasicRedeemable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "adrt:CommonStockSharesAuthorizedRedemption", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "role": "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R23": { "firstAnchor": { "ancestors": [ "span", "p", "adrt:PrivatePlacement", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Initial Public Offering (Details Narrative)", "role": "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "shortName": "Initial Public Offering (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "adrt:InitialPublicOffering", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2021-11-192021-11-20_us-gaap_IPOMember", "decimals": "INF", "lang": null, "name": "adrt:SharesPurchasePricePerShares", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "p", "adrt:PrivatePlacement", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Private Placement (Details Narrative)", "role": "http://adrt.com/role/PrivatePlacementDetailsNarrative", "shortName": "Private Placement (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R25": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Related Party Transactions (Details Narrative)", "role": "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2021-02-23", "decimals": "INF", "lang": null, "name": "adrt:CommonStockParOrStatedValuePerShare1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesIssued", "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "role": "http://adrt.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2021-02-23", "decimals": "0", "lang": null, "name": "us-gaap:CommonStockValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - The following table presents information about the Company\u2019s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determi (Details)", "role": "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails", "shortName": "The following table presents information about the Company\u2019s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determi (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "adrt:CommonStockSharesAuthorizedRedemption", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONDENSED BALANCE SHEETS (unaudited) (Parenthetical)", "role": "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "shortName": "CONDENSED BALANCE SHEETS (unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2021-02-222021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DirectOperatingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "role": "http://adrt.com/role/UnauditedCondensedStatementsOfOperations", "shortName": "UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2021-02-222021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DirectOperatingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2021-02-232021-03-31_us-gaap_RetainedEarningsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "role": "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2021-02-232021-03-31_us-gaap_RetainedEarningsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2021-02-222021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS", "role": "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidExpensesOther", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:OrganizationAndBusinessOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Organization and Business Operations", "role": "http://adrt.com/role/OrganizationAndBusinessOperations", "shortName": "Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:OrganizationAndBusinessOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://adrt.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:InitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Initial Public Offering", "role": "http://adrt.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adtc51022010q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:InitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 17, "tag": { "adrt_AccountingPolicyOnRedeemableSharesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policy on Redeemable Shares" } } }, "localname": "AccountingPolicyOnRedeemableSharesPolicyTextBlock", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adrt_AccretionOfCarryingValueToRedemptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Remeasurement of carrying value to redemption value" } } }, "localname": "AccretionOfCarryingValueToRedemptionValue", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/AsOfMarch312022SharesOfCommonStockReflectedInBalanceSheetAreReconciledInFollowingTableDetails" ], "xbrltype": "monetaryItemType" }, "adrt_AccruedOfferingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued offering costs and expenses" } } }, "localname": "AccruedOfferingCostsAndExpenses", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "adrt_CashHeld": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "cash held from out side" } } }, "localname": "CashHeld", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights11": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share price per unit" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights11", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_CommonStock0.001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, $0.001 par value" } } }, "localname": "CommonStock0.001ParValueMember", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "domainItemType" }, "adrt_CommonStockParOrStatedValuePerShare1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare1", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_CommonStockSharesAuthorizedRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized redemption", "verboseLabel": "[custom:CommonStockSharesAuthorizedRedemption-0]" } } }, "localname": "CommonStockSharesAuthorizedRedemption", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adrt_CommonStockSubjectToPossibleRedemption1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock subject to possible redemption" } } }, "localname": "CommonStockSubjectToPossibleRedemption1", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/AsOfMarch312022SharesOfCommonStockReflectedInBalanceSheetAreReconciledInFollowingTableDetails" ], "xbrltype": "monetaryItemType" }, "adrt_CommonStockValueRedemption": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock subject to possible redemption, 11,500,000 shares at redemption value" } } }, "localname": "CommonStockValueRedemption", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "adrt_DeferredUnderwritingCommissions": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred underwriting commissions" } } }, "localname": "DeferredUnderwritingCommissions", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "adrt_DisclosureInitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering" } } }, "localname": "DisclosureInitialPublicOfferingAbstract", "nsuri": "http://adrt.com/20220331", "xbrltype": "stringItemType" }, "adrt_DisclosureOrganizationAndBusinessOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization And Business Operations" } } }, "localname": "DisclosureOrganizationAndBusinessOperationsAbstract", "nsuri": "http://adrt.com/20220331", "xbrltype": "stringItemType" }, "adrt_DisclosurePrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement" } } }, "localname": "DisclosurePrivatePlacementAbstract", "nsuri": "http://adrt.com/20220331", "xbrltype": "stringItemType" }, "adrt_EarningsPerShareBasicAndDilutedOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted net loss per share attributable to common stockholders", "verboseLabel": "Basic and diluted net loss per common stock non redemable" } } }, "localname": "EarningsPerShareBasicAndDilutedOne", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/FollowingTableReflectsCalculationOfBasicAndDilutedNetLossPerCommonShareInDollarsExceptPerShareAmountsDetails", "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "adrt_EarningsPerShareBasicAndDilutedRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted net income per share attributable to common stock subject to redemption", "verboseLabel": "Basic and diluted net loss per common stock redemable" } } }, "localname": "EarningsPerShareBasicAndDilutedRedemption", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/FollowingTableReflectsCalculationOfBasicAndDilutedNetLossPerCommonShareInDollarsExceptPerShareAmountsDetails", "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "adrt_EmergingGrowthCompanyStatusPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Emerging Growth Company Status" } } }, "localname": "EmergingGrowthCompanyStatusPolicyTextBlock", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adrt_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_InitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InitialPublicOffering", "verboseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOffering", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "adrt_InterestIncome": { "auth_ref": [], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "InterestIncome", "negatedLabel": "Interest earned on Trust Account" } } }, "localname": "InterestIncome", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adrt_IssuanceCostsAllocatedToCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance costs allocated to common stock" } } }, "localname": "IssuanceCostsAllocatedToCommonStock", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/AsOfMarch312022SharesOfCommonStockReflectedInBalanceSheetAreReconciledInFollowingTableDetails" ], "xbrltype": "monetaryItemType" }, "adrt_LiabilitiesSharesSubjectToRedemptionAndShareholdersDeficitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesSharesSubjectToRedemptionAndShareholdersDeficitAbstract", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "adrt_NetIncomeLossAvailableToCommonStockholdersBasicRedeemable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Allocation of net loss, as adjusted redeemable" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicRedeemable", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/FollowingTableReflectsCalculationOfBasicAndDilutedNetLossPerCommonShareInDollarsExceptPerShareAmountsDetails" ], "xbrltype": "monetaryItemType" }, "adrt_OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offering Costs associated with the Initial Public Offering" } } }, "localname": "OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adrt_OrganizationAndBusinessOperations": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Business Operations" } } }, "localname": "OrganizationAndBusinessOperations", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "adrt_PaymentOfDeferredOfferingCostsBySponsorInExchangeForIssuanceOfCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Payment of deferred offering costs by the Sponsor in exchange for the issuance of common stock" } } }, "localname": "PaymentOfDeferredOfferingCostsBySponsorInExchangeForIssuanceOfCommonStock", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adrt_PaymentOfOfferingCosts": { "auth_ref": [], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PaymentOfOfferingCosts", "negatedLabel": "Payments of offering costs" } } }, "localname": "PaymentOfOfferingCosts", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adrt_PrepaidAssetsNoncurrentPortion": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Prepaid expenses, non-current" } } }, "localname": "PrepaidAssetsNoncurrentPortion", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "adrt_PrivatePlacement": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PrivatePlacement", "verboseLabel": "Private Placement" } } }, "localname": "PrivatePlacement", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "adrt_PrivatePlacement1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement 1 [Member]" } } }, "localname": "PrivatePlacement1Member", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_PrivatePlacement2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement 2 [Member]" } } }, "localname": "PrivatePlacement2Member", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_ProceedsAllocatedToPrivatePlacementWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Proceeds allocated to Public Warrants" } } }, "localname": "ProceedsAllocatedToPrivatePlacementWarrants", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/AsOfMarch312022SharesOfCommonStockReflectedInBalanceSheetAreReconciledInFollowingTableDetails" ], "xbrltype": "monetaryItemType" }, "adrt_ProceedsFromIssuanceOfCommonStock1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfCommonStock1", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/AsOfMarch312022SharesOfCommonStockReflectedInBalanceSheetAreReconciledInFollowingTableDetails" ], "xbrltype": "monetaryItemType" }, "adrt_RedeemableSharesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "As of March 31, 2022, the shares of common stock reflected in the balance sheet are reconciled in the following table:" } } }, "localname": "RedeemableSharesTableTextBlock", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "adrt_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50" } } }, "localname": "RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "domainItemType" }, "adrt_SaleOfStockDescriptionOfTransaction1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of stock issuance" } } }, "localname": "SaleOfStockDescriptionOfTransaction1", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "adrt_SaleOfStockPricePerShare1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:SaleOfStockPricePerShare1-0]" } } }, "localname": "SaleOfStockPricePerShare1", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/PrivatePlacementDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_SaleOfStockPricePerShare3": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise price per share" } } }, "localname": "SaleOfStockPricePerShare3", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/PrivatePlacementDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_SharesPurchasePricePerShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares purchase price (in dollars per share)" } } }, "localname": "SharesPurchasePricePerShares", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_StockIssuedDuringPeriodSharesNewIssues2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues2", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adrt_StockIssuedDuringPeriodSharesNewIssues3": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock issued during period new issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues3", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adrt_StockIssuedDuringPeriodSharesNewIssuesOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StockIssuedDuringPeriodSharesNewIssuesOne", "verboseLabel": "Stock Issued During Period, Shares, New Issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssuesOne", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adrt_UnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Underwriting fees" } } }, "localname": "UnderwritingFees", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_WarrantInstrumentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Instruments" } } }, "localname": "WarrantInstrumentsPolicyTextBlock", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adrt_WeightedAverageNumberOfShareOutstandingBasicAndDilutedOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted weighted average shares outstanding, common stock", "verboseLabel": "Basic and diluted weighted average shares outstanding non redeemable" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDilutedOne", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/FollowingTableReflectsCalculationOfBasicAndDilutedNetLossPerCommonShareInDollarsExceptPerShareAmountsDetails", "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "adrt_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted weighted average shares outstanding, common stock subject to redemption", "verboseLabel": "Basic and diluted weighted average shares outstanding redeemable" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDilutedRedemption", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/FollowingTableReflectsCalculationOfBasicAndDilutedNetLossPerCommonShareInDollarsExceptPerShareAmountsDetails", "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "adrt_WorkingCapitalAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Working capital" } } }, "localname": "WorkingCapitalAmount", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_WorkingCapitalLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Working capital loan" } } }, "localname": "WorkingCapitalLoan", "nsuri": "http://adrt.com/20220331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r240", "r242", "r243" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r16", "r190" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r24", "r25", "r171", "r172", "r173", "r174", "r175", "r176" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r10", "r190" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r47", "r48", "r49", "r141", "r142", "r143", "r161" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r6", "r45", "r85", "r87", "r91", "r94", "r100", "r101", "r102", "r103", "r104", "r105", "r106", "r107", "r108", "r109", "r110", "r154", "r158", "r169", "r188", "r190", "r209", "r216" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r3", "r15", "r45", "r94", "r100", "r101", "r102", "r103", "r104", "r105", "r106", "r107", "r108", "r109", "r110", "r154", "r158", "r169", "r188", "r190" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r163" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustCurrent": { "auth_ref": [ "r42" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Cash and securities held in Trust Account" } } }, "localname": "AssetsHeldInTrustCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Transaction cost" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r5", "r190", "r226", "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r5", "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash, end of the period", "periodStartLabel": "Cash, beginning of the period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r35", "r170" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r5" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Current asset - cash" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r7", "r8", "r9", "r43", "r45", "r61", "r62", "r63", "r66", "r67", "r72", "r73", "r74", "r94", "r100", "r104", "r105", "r106", "r109", "r110", "r114", "r115", "r117", "r121", "r127", "r169", "r245" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of expense or revenue offset related to the warrants or rights.", "label": "Class of warrant or right, expense or revenue recognized" } } }, "localname": "ClassOfWarrantOrRightExpenseOrRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r19", "r211", "r219" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r96", "r97", "r98", "r99", "r228" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r47", "r48", "r161" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in dollars per share)", "verboseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r9", "r127" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares, outstanding", "periodEndLabel": "Balance, end (in shares)", "periodStartLabel": "Balance at beginning (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r9", "r190" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r77", "r215" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r29" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "verboseLabel": "Accrued offering costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectOperatingCosts": { "auth_ref": [ "r30" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate direct operating costs incurred during the reporting period.", "label": "Formation and operating costs" } } }, "localname": "DirectOperatingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r68", "r69" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Loss per Share of Common Stock" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r24", "r25", "r26", "r47", "r48", "r49", "r51", "r56", "r58", "r71", "r95", "r127", "r129", "r141", "r142", "r143", "r150", "r151", "r161", "r171", "r172", "r173", "r174", "r175", "r176", "r179", "r221", "r222", "r223" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r163", "r164", "r168" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "The following table presents information about the Company\u2019s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r111", "r112", "r113", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r140", "r164", "r193", "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r111", "r132", "r133", "r138", "r140", "r164", "r193" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r111", "r112", "r113", "r132", "r133", "r138", "r140", "r164", "r194" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r111", "r112", "r113", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r140", "r164", "r195" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r111", "r112", "r113", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r140", "r193", "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r23", "r144", "r145", "r146", "r147", "r148", "r149" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Deferred offering costs included in accrued offering costs and accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in current assets and current liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r37" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r27", "r84", "r177", "r178", "r213" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r32", "r83" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Trust interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r17", "r45", "r88", "r94", "r100", "r101", "r102", "r104", "r105", "r106", "r107", "r108", "r109", "r110", "r155", "r158", "r159", "r169", "r188", "r189" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r14", "r45", "r94", "r169", "r190", "r210", "r218" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r4", "r18", "r45", "r94", "r100", "r101", "r102", "r104", "r105", "r106", "r107", "r108", "r109", "r110", "r155", "r158", "r159", "r169", "r188", "r189", "r190" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities Held in Trust Account" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r35" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r35" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r35", "r36", "r38" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r21", "r22", "r26", "r28", "r38", "r45", "r50", "r52", "r53", "r54", "r55", "r57", "r58", "r64", "r85", "r86", "r89", "r90", "r92", "r94", "r100", "r101", "r102", "r104", "r105", "r106", "r107", "r108", "r109", "r110", "r162", "r169", "r212", "r220" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit", "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r52", "r53", "r54", "r55", "r59", "r60", "r65", "r67", "r85", "r86", "r89", "r90", "r92" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Allocation of net loss, as adjusted non redeemable" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTableReflectsCalculationOfBasicAndDilutedNetLossPerCommonShareInDollarsExceptPerShareAmountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of noncash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r33" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating cost" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r85", "r86", "r89", "r90", "r92" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOwnershipInterestsOfferingCosts": { "auth_ref": [ "r130" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of offering costs allocated to the other unit holders.", "label": "Offering cost" } } }, "localname": "OtherOwnershipInterestsOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r8", "r114" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)", "verboseLabel": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r8", "r114" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r8", "r190" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementDetailsNarrative", "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r34" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from option exercise", "verboseLabel": "Proceeds from issuance of private placement warrants" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r139", "r182", "r183" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r139", "r182", "r185", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r180", "r181", "r183", "r186", "r187" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/FollowingTablePresentsInformationAboutCompanysAssetsThatAreMeasuredAtFairValueOnRecurringBasisAtMarch312022AndDecember312021AndIndicatesFairValueHierarchyOfValuationInputsCompanyUtilizedToDetermiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r11", "r129", "r190", "r217", "r224", "r225" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r47", "r48", "r49", "r51", "r56", "r58", "r95", "r141", "r142", "r143", "r150", "r151", "r161", "r221", "r223" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "auth_ref": [ "r153", "r156", "r157" ], "lang": { "en-us": { "role": { "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.", "label": "Sale of stock, description of transaction" } } }, "localname": "SaleOfStockDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/PrivatePlacementDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementDetailsNarrative", "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of stock, price per share", "verboseLabel": "Share price per unit" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": { "auth_ref": [ "r62", "r67", "r70" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.", "label": "The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r184", "r185" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r41", "r46" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SponsorFees": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.", "label": "Sponsor fees" } } }, "localname": "SponsorFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r7", "r8", "r9", "r43", "r45", "r61", "r62", "r63", "r66", "r67", "r72", "r73", "r74", "r94", "r100", "r104", "r105", "r106", "r109", "r110", "r114", "r115", "r117", "r121", "r127", "r169", "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r20", "r24", "r25", "r26", "r47", "r48", "r49", "r51", "r56", "r58", "r71", "r95", "r127", "r129", "r141", "r142", "r143", "r150", "r151", "r161", "r171", "r172", "r173", "r174", "r175", "r176", "r179", "r221", "r222", "r223" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/Cover", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r47", "r48", "r49", "r71", "r196" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/Cover", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Issuance of common stock to sponsor (in shares)", "verboseLabel": "Shares issued for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r8", "r9", "r127", "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of common stock to Sponsors (in shares)", "verboseLabel": "Issuance of common stock to sponsors (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Issuance of common stock to sponsor", "verboseLabel": "Aggregate purchase price" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r9", "r12", "r13", "r45", "r93", "r94", "r169", "r190" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Balance as of February 22, 2021 (inception)", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r44", "r115", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r129", "r131", "r160" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r191", "r192" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementDetailsNarrative", "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnrealizedGainOnSecurities": { "auth_ref": [], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease), resulting in a gain, in the difference between the fair value and the carrying value, or in the comparative fair values, of securities held at each balance sheet date, that was included in earnings for the period.", "label": "Income from investments held in trust account", "negatedLabel": "Income from investments held in Trust Account" } } }, "localname": "UnrealizedGainOnSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows", "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r75", "r76", "r78", "r79", "r80", "r81", "r82" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant terms" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770" }, "r131": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r187": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r192": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r229": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r230": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r231": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r232": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r233": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r234": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r235": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r236": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r237": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r238": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r239": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r240": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r241": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r242": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r243": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r244": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r245": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r246": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r247": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r248": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r249": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r46": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" } }, "version": "2.1" } ZIP 45 0001214659-22-007321-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-22-007321-xbrl.zip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end

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